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       Abstract: Artificial Metalloenzymes; Modified Proteins as Tuneable 
Transition Metal Catalysts and their Application in Oxidative Lignin 
Degradation. 
 
 
The selective oxidation of organic molecules is fundamentally important to life and immensely 
useful in industry. Metalloenzyme catalysed oxidations often display exquisite substrate 
specificity as well as regio and/or stereoselectivity. Huge strides have occurred in the field of 
biocatalysis in recent years. Work has developed by taking inspiration from nature’s enzymes, 
to use directed evolution and engineering methods to create tailor made catalysts. Artificial 
Metalloenzymes (ArMs) provide the possibility to expand this repertoire further by combining 
the advantageous features of enzymes with the versatile reaction scope of transition metals. 
 
The initial chapter in this thesis takes a look into recent literature about artificial 
metalloenzymes and their application in oxidation catalysis. 
 
Chapter two describes the design rationale and synthesis of protein templates and synthetic 
cofactors for the development of artificial metalloenzymes. Successful modification was 
achieved for a wide library of nitrogen donor ligands, creating an array of artificial 
metalloenzymes that can be tested in catalytic reactions. In the absence of a crystal 
structure of the modified protein, UV and CD analysis were carried out to gather 
characteristic information about the artificial metalloenzymes and their metal binding 
properties. An investigation was also carried out to determine the most accurate method to 
calculate protein concentration once it has been modified with a cofactor. 
 
The third chapter describes the application of protein engineering to increase the 
thermostability of the target protein. Variants of an artificial metalloenzyme were created by 
rational design using structural and bioinformatic information. The variants were tested to 
identify mutations that enhanced the stability of the protein scaffold. Significant increases in 
melting temperature were observed in a number of the modified metalloenzymes. Their 
ability to withstand higher reaction temperatures resulted in increased activity in the 
hydroformylation of 1-octene, with >5-fold improvements in turnover numbers (TON). 
 XII 
 
The fourth chapter reports the use of artificial metalloenzymes in oxidation catalysis. In 
particular their application to the degradation of lignin is investigated. Using a model 
compound that mimics the most abundant linkage within lignin as a substrate, a wide array 
of artificial metalloenzymes were tested to study if any oxidation or cleavage occurs. 
Investigations were carried out to find the optimum conditions varying catalyst loading and 
buffer/solvent composition. Complete selective conversion to ketone product is observed 
using SCP-2L A100C modified with a tris(2-pyridylmethyl) amine based cofactor, coordinated 
to Fe(OTf)2.2MeCN. Engineering the protein scaffold to incorporate glutamic acid was found 
to improve the ArM activity, showing that rational design of the protein environment using 
metal binding amino acids can be a method to improve the overall activity of an artificial 
metalloenzyme. 
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Chapter 1 - Introduction to Artificial Metalloenzymes and their application to Oxidation 
Catalysis 
 
The selective oxidation of organic molecules is fundamentally important to life and immensely 
useful in industry.1, 2 Metalloenzyme catalysed oxidations often display exquisite substrate 
specificity as well as regio- and/or stereoselectivity.3 Huge strides have occurred in the field 
of biocatalysis in recent years. Work has developed by taking inspiration from nature’s 
enzymes, to using directed evolution and engineering methods to create tailor made 
catalysts. Artificial Metalloenzymes (ArMs) provide the possibility to expand this repertoire 
further by combining the advantageous features of enzymes with the versatile reaction scope 
of transition metals. 
 
1.1 Nature’s enzymes for oxidation reactions 
 
Nature has evolved over billions of years to utilise enzymes for extremely efficient and 
selective multi-step reactions. Metalloenzymes have been used increasingly within oxidation 
catalysis and they often outperform the low molecular weight metal complexes utilised by 
chemists. Metalloenzyme catalyzed oxidations often demonstrate high substrate specificity 
alongside high levels of enantio- and regio-selectivity.4 Naturally occurring enzymes have 
been shown to perform oxidative reactions including hydroxylation, dihydroxylation of 
aromatic and aliphatic C-H bonds, epoxidation, Baeyer-Villiger oxidation of ketones to 
lactones, and halohydrin formation from alkenes.5 Enzymatic oxidation reactions have been 
introduced on an industrial scale,  and interesting examples can be seen in Scheme 1. Within 
the food and wine industry glucose oxidase (GO) is being used for the oxidation of D-glucose 
to D-gluconolactone (Scheme 1a).6 A well-known industrial process that utilises enzymatic 
oxidation is the two-step process for the synthesis of ethyl (R)-4-cyano-3-hydroxybutyrate, an 
important intermediate in atorvastatin production. 7 
 Another example is the production of hydroxy amino acids; their antidiabetes activity make 
them a useful target. An example of their synthesis can be seen in Scheme 1b using L-
isoleucine dioxygenase (IDO).8 The GO and IDO examples are interesting because these utilise 
the wild type enzymes whereas a significant number of current examples of industrial 
applications use designed mutants.  More recently, examples have appeared in medicinal 
chemistry, such as the use of a mutant monoamine oxidase in the production of cyclic imine 
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intermediates for the synthesis of telapravir, a pharmaceutical drug used for the treatment 
of hepatitis C (Scheme 1c).9 In order for enzymes to be used in industrial applications, they 
need to be of high stability and productivity. Therefore, in many circumstances protein 
engineering is used to enhance the natural ability of the enzyme or adapt an enzyme to 
specific needs.  
 
Scheme 1: Industrial Examples utilising natural enzymes. 
 a) Oxidation of D-glucose, b) production of hydroxy amino acids c) Synthesis of telapravir. 
(αKG = α-ketoglutarate, KPi = potassium phosphate buffer). 10 
 
There are a wide range of different oxidative enzyme types, but they predominately use iron 
or copper metal centres.11  In Figure 1 the different active sites found within nature’s oxidative 
enzymes are shown. Iron and copper ions are the metal ions of choice for many biological 
oxidative systems due to their natural abundance, electronic properties and accessible redox 
potentials. I will briefly discuss key examples of oxidation catalysis from each different class 
of oxidation enzymes. 
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a) 
 
 
 
 
 
 
b) 
 
 
 
c) 
 
 
 
 
 
d) 
 
 
 
 
 
Figure 1: Diagrams to represent the different Iron containing active sites found within nature 
a) P450 Heme Active Site (PDB 1JPZ) b) 2-His-1-carboxylate facial triad motif, His(Green) Asp 
(Blue) Water (Yellow) (PDB 1RXF) c) [2Fe-2S] Cluster (PDB 1UUW) d) Di-iron centre seen in 
monooxygenases Glu (Orange) His (Green) Water (Yellow) (PDB 1MTY).10 
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1.1.2 Heme Containing Oxidative Enzymes 
The heme containing enzymes are among the most studied classes of oxidative enzymes, and 
include peroxidases, catalases and P450s. These redox enzymes can be used to activate 
hydrogen peroxide or molecular oxygen, and transfer oxygen to the substrate via high-valent 
iron-oxo intermediates (Scheme 2).12 The active site comprises of a porphyrin ring anchored 
to the protein backbone through a histidine or cysteine residue and also via ionic, van der 
Waals and hydrogen bonding interactions (Figure 1a).13 In nature, different protoporphyrin 
rings are found, and consequently different types of heme can exist. Generally, iron-
protoporphyrin IX complex, known as “heme b”, is referred to as heme.  
An important intermediate of the heme enzyme’s catalytic cycle is Compound I, an oxoiron(IV) 
porphyrin π cation radical, which has the ability to oxidize a variety of substrates, a factor 
often exploited in biomimetic approaches to oxidative catalysis.14,15  
 
 
 
 
 
 
 
 
 
 
Scheme 2: The P450 catalytic cycle highlighting important intermediates. Centre of cycle 
indicates the active site with a conserved threonine and cysteine.10 
The most extensively studied type of heme containing enzymes is the cytochrome P450 
family.16,17,18 Some of the most significant reactions by P450s are monooxygenation of 
aliphatic and aryl C-H bonds, alkene epoxidation and sulfoxidation. Although naturally 
occurring P450 enzymes possess a narrow substrate scope, their high catalytic activity and 
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solubility provide an attractive starting point for a bioengineering approach to adapt to other 
substrates.  
Bioengineering of P450s has resulted in impressive regioselectivities in alkane oxidation.  For 
the selective oxidation of n-octane, the P450BM3 mutant 77-9H obtained via directed 
evolution gave rise to 52% selectivity for the terminal position (Scheme 3a). Generally, <10% 
of the products show 1-octanol for P450BM3 enzymes.  The regioselectivity was shown to be 
octane specific as the results were not that good for other hydrocarbon chain lengths.19 The 
same authors have also targeted the hydroxylation of more complex targets20, 21 and explored 
epoxidation22 utilizing the chirality in the protein scaffold to give rise to enantioselective 
transformations (Scheme 3b and c).  
 
 
Scheme 3: Example applications of bioengineered P450 enzymes 
 a) Hydroxylation of Octane using P450BM3 77-9H, b) Enantioselective Epoxidation of Terminal 
Alkenes Scheme, c) Oxidation of α–aryl-acetic acid esters. (TTN = total turnover number).10 
1.1.2 Non-heme Iron Oxidative Enzymes  
Monooxygenases produce the selective oxidation of a variety of substrates depending on the 
subtype of enzymes and in all cases they use molecular oxygen as an oxidant.23   
A class of monooxygenases that has been utilised within the pharmaceutical industry are the 
Baeyer-Villiger monooxygenases (BVMO), which are capable of oxidation of both linear and 
cyclic ketones to esters and lactones using molecular oxygen. The BVMO enzymes have been 
applied within microbes, as enzyme extracts and as recombinant enzymes in organic 
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synthesis.24 Several reviews have appeared in recent years describing the use of BVMOs in 
organic reactions such as steroid transformations, degradation of ketones, heteroatom 
oxidation, aldehyde oxidation and epoxidation.25,26 The reactions, however, are complicated 
due to the need for regeneration and retention of a cofactor. Significant progress has been 
made in co-factor recycling with solutions such as immobilization, continuous substrate 
feeding, resins and using biphasic reactions. Regeneration is often achieved using a parallel 
enzymatic or non-enzymatic redox reaction. A recently developed example involved protein 
engineering on a BVMO to invert the enantioselectivity and improve the activity, stability and 
chemo-selectivity of the enzyme. This novel BVMO catalyses a sulfoxidation reaction to give 
the active pharmaceutical ingredient Esomeprazole (Scheme 4). Nevertheless, more progress 
is needed on improving the stability and efficiency of BVMO enzymes for their effective use 
within organic synthesis.    
 
 
Scheme 4: BVMO sulfoxidation to synthesise Esomeprazole.10 
 
1.1.3 Copper Containing Oxidative Enzymes 
Copper containing oxidases and oxygenases comprise a large class of enzymes that use 
intriguing mechanisms to bind and activate oxygen to oxidize organic substrates.27 The active 
sites within these copper-containing enzymes contain a variable number of copper ions. 
Laccases are the largest subgroup of blue multicopper oxidases (MCO); they have the 
capability to catalyze the oxidation of various aromatic substrates including ortho- and para- 
diphenols, aminophenols, polyphenols, as well as polyamines and aryl diamines, and 
inorganic ions.28 They contain four copper atoms in the active site, which are organised into 
three different copper centres (Figure 2).29 Most substrates used by laccase enzymes are 
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phenols with redox potentials similar to that of the laccase itself; hence their ability to reduce 
the T1 centre.30  
 
 
 
 
 
 
Figure 2: Laccase Active Site (PDB 25HU) illustrating the trinuclear cluster (TNC) of copper 
atoms and the single copper atom known as a T1 site (His in blue, Cys in Green).10 
Laccase proteins are able to maintain stability at 60 °C, which is beneficial for developing 
large-scale processes that require high temperatures. However, they have low substrate 
specificity and the enzyme is difficult to recycle. The redox potential of laccases prevents the 
enzyme from oxidizing primary alcohols but a biphasic system of laccase with a chemical 
mediator, such as TEMPO, has been successfully developed.31  
 
1.2 Advantages in the design of Artificial metalloenzymes 
 
The line between simply mutating an existing metalloenzyme and engineering a novel hybrid 
catalyst is quite ambiguous.  The idea behind ArMs is to combine the advantages of both 
enzymes and transition metal catalysts to produce an ideal system. Expanding upon the vast 
scope of enzymes created through evolution by introducing artificial metals creates 
opportunities for exploring a wider range of enzyme-catalyzed reactions. 
 
Catalysts which have been designed by using scaffolds provided by nature offer many 
possibilities for tackling such selectivity problems, as they are widely studied, and a wide array 
of engineering tools are available. Nature’s enzymes are the product of evolution and 
generations of mutations. They can continuously update and optimize their enzymatic 
repertoires. Directed evolution is a protein engineering tool that can mimic evolution by 
artificial selection.32 This method has been widely used to broaden the substrate scope of 
enzymes or improve their selectivity and/or stability in a targeted manner. A directed 
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evolution approach can also be applied to ArMs, as shown by random mutagenesis carried 
out by error-prone PCR to generate dirhodium ArM variants with improved enantioselectivity 
for a model styrene cyclopropanation reaction.33 
Introducing non-native metal ions into a protein can expand the repertoire of protein 
functionalities and its applications. The initial work was published in 1978 by Wilson and 
Whitesides where they reported a metalloenzyme34 that catalyzes asymmetric olefin 
hydrogenation as a homogenous catalyst. The limitations in structural characterization and 
analysis slowed down the progression of this area at that time. The development of rational 
design of proteins and metal complexes has increased in the last decade dramatically due to 
development of bioanalytical techniques and also a larger crossover between biosciences and 
inorganic chemistry. 
The artificial enzyme is unique compared to other catalysts and enzymes, in that two levels 
of optimization can be envisioned. The first level is the first coordination sphere containing 
the transition metal / ligand environment, which is open to optimization using synthetic 
techniques usually within the ligand moiety. The second coordination sphere is the 
surrounding protein scaffold; this can be fine-tuned using protein engineering.35,36,37 The 
concept behind the generation of ArMs is illustrated in Fig 3.  
 
 
Figure 3: Concept of artificial metalloenzymes and opportunities for catalyst optimisation.10 
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There are no current examples of ArM’s being used in industry. However, recent examples 
have looked at the possible application of ArM’s in the pharmaceutical industry. This is an 
interesting example that has shown the transformation of wild type surface receptors of living 
cells into ArMs.38 Work using the Stretavidin-biotin technology has also been applied in vivo 
to catalyze olefin metathesis.39 While there have been remarkable development’s in the 
activity of ArM’s in recent years, the activities remain much lower than those seen from 
natures enzymes. One example of a reconstituted artificical metalloenzyme made from a 
P450 enzyme containing an iridium porphyrin exhibits kinetic parameters similar to those of 
natural enzymes. This system catalyzed the insertion of carbenes into C-H bonds with up to 
98% ee, 35000 TON and 2500 h-1 TOF.40 
 
1.3 Strategies for creating artificial metalloenzymes 
 
The several strategies for creating these ArMs can be divided into two main categories: non-
covalent anchoring and covalent modification.41, 42, 43 The non-covalent approach can be 
subdivided into dative anchoring and supramolecular anchoring. Dative anchoring is utilizing 
the affinity of a protein for a specific transition metal.  
 
The first report to use the dative anchoring approach was Kaiser et al in 1976. 
Carboxypeptidase A (CPA) was used, which in its native form is a zinc-containing enzyme that 
demonstrates peptidase and esterase activity. The Kaiser group replaced the zinc atom with 
a copper atom, creating a catalyst capable of oxidizing ascorbic acid. The metal atom 
exchange was a tremendous alteration, and the active site geometry changed from square 
planar towards a tetrahedral shape, resulting in different enzyme activity.44 However, this can 
be problematic as proteins can have multiple sites for metal binding. Reetz reported the 
creation of an artificial copper binding site in the synthase subunit of imidazole glycerol 
phosphate synthase from Themotoga maritima (tHisF).45 The introduced motif contained two 
histidine and one aspartic acid residues located at a strategic position to bind a copper atom. 
The system was then applied to copper catalyzed Diels-Alder reaction between azachalcone 
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and cyclopentadiene. An improved activity compared to the native protein was seen and 35% 
ee was obtained.  
 
Supramolecular anchoring is based on a high affinity protein-substrate interaction such as 
biotin-(strept)avidin (dissociation constant in the order of 10-14 M).46 The use of avidin-biotin 
as a technique to introduce a metal complex into a protein scaffold has been explored very 
successfully by the group of Ward. The initial work from Ward came from the rhodium-
diphosphine catalyzed hydrogenation of N-protected dehydroaminoacids producing an ee of 
up to 95%. This was carried out using streptavidin instead of avidin, which improved the 
catalytic system due to a deeper binding pocket.47 This approach combines the advantages of 
simple catalyst preparation, with resultant fast generation and screening of mutant 
libraries.48 However, the anchoring may not always be specific to one region of the scaffold. 
A whole range of reactions were performed with ArM’s based on this strategy (e.g. olefin 
metathesis49 and asymmetric transfer hydrogenations of imines)50 
 
The most effective way of achieving specific binding of a co-factor, is to covalently tether it to 
a protein scaffold. The covalent modification of protein structures is performed by site 
selective modification of the protein with a transition metal complex, for example by making 
use a nucleophilic amino acid residue. Cysteine, with its strongly nucleophilic thiol 
functionality is a popular choice for bioconjugation owing to its relatively low occurrence 
(1.7%) in wild type proteins. The important advantage of covalent modification over 
supramolecular anchoring is that one is not limited to a certain protein scaffold. Protein hosts 
can be selected based on desired characteristics such as substrate binding, stability and shape 
of the binding site.  Site directed mutagenesis to introduce a cysteine residue allows the co-
factor to be anchored at any site in the protein with high specificity.  
 
Kaiser et al. were the first to create an ArM via covalent modification of an amino acid by 
alkylation of C25 in papain with bromoacetyl functionalized flavins.51 This work was the 
inspiration for much future work for the creation of ArM’s using the same covalent 
attachment procedure.  Reetz and De Vries suggested that papain was limited as a protein 
scaffold within an ArM system because of its large conformational flexibility. It is suggested 
that structural rigidity is an important factor in ArM activity. By reducing the number of 
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accessible structures of the catalytic species conformational dynamics of the protein  can be 
limited and/or the functional interactions between the host and the metal-complex can be 
increased.52,53 
 
With the development of modelling software54, 55de novo design has begun to appear, 
resulting in the  design of completely new protein structures. A well-designed example is the 
novel “Due Ferri” di-iron complex containing protein.56 DeGrado and co-workers designed a 
tetra-helical unit, with an iron binding site made up of glutamate and histidine residues.  
 
 
1.4 Application of artificial metalloenzymes hybrid catalysts in oxidation reactions 
  
Several elegant approaches for the design and application of artificial hybrid oxidation 
catalysts are highlighted based on the type of oxidation reactions performed.57,58   
1.4.1 Alcohol oxidation 
Oxidation of alcohols is an important reaction in organic chemistry and new mild and green 
methodology is still in demand. Several elegant bioinspired innovations have been reported 
using hydrogen transfer pathways.59, 60, 61 One interesting example of ArM catalysed alcohol 
oxidation is the oxidation of 1-phenylethanol. This was achieved using a hybrid catalyst 
developed by supramolecular anchoring of different ruthenium, iridium and rhodium 
modified biotins (Scheme 5).62 Benzyl alcohol and cyclohexanol could also be converted into 
the corresponding aldehyde and ketone respectively (68% and 80% conversion).  
 
Scheme 5: Benzyl alcohol oxidation using ruthenium amino-sulfamide biotin complexes 
anchored via supramolecular interaction to streptavidin. 10 
An ArM for the oxidation of catechol derivatives was designed by reprogramming a bacterial 
metallo-b-lactamase into a catechol oxidase.63 Subsequently, a triple mutant was designed 
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based on computer-assisted structural analysis of the binding site in order to effectively 
incorporate a dinuclear copper site.  
1.4.2 Sulfoxidation 
Asymmetric sulfoxidation of methyl phenyl sulfide and similar substrates is a benchmark 
reaction for assessment of hybrid oxidation catalysts. The aim is obtaining enantioselectivity 
as it demonstrates the influence of chiral environment of the protein host on the reaction. 
Ward and co-workers created a highly selective catalyst system for this reaction reaching up 
to 93% ee for naphthalene methyl sulfide using tert-butyl hydroperoxide as oxidant. They 
employed the dative approach incorporating a vanadyl ion in the biotin binding site of 
streptavidin (Scheme 6).64 They reasoned that the hydrogen bonds that allow biotin to bind 
strongly are perfectly suited for coordinating the vanadyl ion while the hydrophobic residues 
involved in biotin binding are left free for substrate interactions.   
Application of the supramolecular interaction between antibodies and metal complexes to 
obtain enantioselective sulfoxidation catalysts has also been reported (ee's up to 45% R, and 
43% S).65,66,67 In addition to supramolecular methods, covalent anchoring has also been 
applied to combine manganese salphen complexes with myoglobin (up to 60% ee).68,69 
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Scheme 6: (Enantioselective) sulfoxidation by a) complex resulting from the interaction of 
streptavidin with VOSO4 b) Supramolecularly anchored manganese corroles into serum 
albumins 10 
A simple biomimetic oxidation system was produced by combining metal complexes of 
amphiphilic corroles with serum albumins. When used in asymmetric sulfoxidation up to 75% 
ee is seen.70 One drawback of this approach is that synthesis of asymmetric ligands for 
complexes such as chiral manganese and iron corrole complexes can be extremely time 
consuming and difficult, compared to achiral derivatives.  
1.5.3. C=C and C-H bond oxygenation 
The group of Mahy reported artificial heme containing enzymes which are able to oxidise 
guaiacol and o-dianiside with hydrogen peroxide.71  These were prepared from Xylanase A, an 
enzyme that is commercially available. The same group associated manganese porphyrins 
into Xylanase A for the epoxidation of styrene derivatives using potassium peroxymonosulfate 
(Scheme 7).72 With this catalytic system low enantioselectivity was found for the epoxidation 
of styrene (8.5% ee). p-Methoxystyrene gave good enantioselecitivty (80% ee) but conversion 
was also low (up to 17%). 
 
Scheme 7: Enantioselective alkene epoxidation using Mn-porphyrins supramolecularly 
anchored into Xylanase 10A.10  
Natural enzymes are able to catalyze complex cascades of chemical reactions in living cells, 
even in the presence of many other enzyme clusters. This is partly due to efficient 
compartmentalization of the different active sites protecting them from mutual deactivation. 
Being able to mimic such tandem reactions would be highly desirable. One-pot combinations 
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of enzyme reactions with transition metal catalyzed reactions have already been reported73 
but development of such systems is very challenging and only a few examples are reported 
that utilise ArMs.74  Despite its attractiveness, the implementation of cascade reactions with 
an organometallic catalyst and an enzyme is difficult because of the mutual inactivation of 
both catalysts. The artificial transfer hydrogenase was assembled by combining the high 
affinity of streptavidin for biotin with a modified iridium-d6-pianostool complex. This resulted 
in compartmentalization of the hydrogen transfer catalyst and the NADH dependent 
monooxygenase, allowing regeneration of the NADH (Scheme 8). If the reaction was run 
without streptavidin the iridium catalyst was quickly deactivated demonstrating the need for 
compartmentalization.75 
 
Scheme 8: Cascade reaction for the NADH dependent enzymatic hydroxylation of 2-
hydroxybiphenyl coupled to a NADH regeneration process base on an artificial transfer 
hydrogenase (ATHase).10 
1.5 Outlook of this thesis  
In this work the aim is to design and create catalyst systems that can be exploited for a range 
of different reactions. The envisioned target is to look at how ArM’s can be utilised in lignin 
oxidation reactions. Lignin is a complex aromatic polymer that gives plants their structural 
integrity by acting as a resin. The pulp and paper industry produce large quantities of 
extracted lignin and only a small percentage is used commercially, and the rest is simply burnt 
as low value fuel. Where biorefineries focus mainly on the production of aliphatic platform 
chemicals from (hemi)cellulose, the degradation of lignin could provide a renewable source 
of low molecular weight aromatic compounds.76 
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Chapter 2 describes the initial stages of design and synthesis of ArMs and in particular takes 
a look at how they can be characterised by UV and CD spectroscopy.  
Chapter 3 reports how protein engineering can be applied to increase the thermostability of 
a protein scaffold and how this will affect the catalytic activity when used in an ArM system. 
This work is applied to previous work by the Kamer group looking at rhodium-protein 
conjugates in hydroformylation. Protein stability is one of the major limitations for catalytic 
applications as illustrated by the low melting temperature (Tm) and pronounced protein 
precipitation. Increasing the protein stability would allow for a wider range of possible 
reaction conditions and could also increase the activity of the catalyst.  
Chapter 4 describes the application of created ArM systems in the oxidation of lignin model 
compounds. The aim was applying an ArM system instead of a small molecular catalyst to 
improve the selectivity of the reaction in the hope to find a method for the sustainable 
production of high value-added chemicals.  
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Chapter 2 – Design and Characterisation of Artificial Metalloenzymes 
 
2.1 Artificial Metalloenzyme Design 
 
The first step of artificial metalloenzyme design is the choice of protein to be used as a 
scaffold. A set of demands is required to be able to select a suitable protein host from the 
millions of available proteins. Protein hosts are selected based on desired characteristics 
such as substrate binding, stability and shape of the binding site. One vital component when 
selecting a protein scaffold is that a large amount of structural information must be known 
about the protein. Regardless of recent advances in the field of bioengineering, it remains 
difficult to predict the tertiary structure of a protein, solely based on the amino acid 
sequence and so de-novo design of an appropriate structure is troublesome.1 Hence, the 
protein has to be structurally characterised by either X-ray crystallography or solution NMR. 
The next important factor is that the protein requires simple production and purification 
protocols, preferentially resulting in a high yield. Finally, stability of the protein is important. 
Conditions used in catalysis can vary in temperature; pH, solvents and reagents so using a 
protein with high stability will be advantageous.  
 
Successful results have been obtained within the Kamer group using human Steroid Carrier 
Protein SL (SCP-2L), 2,3,4,5  this is one of the three domains of the Human Multifunctional 
Enzyme Type 2 (MFE-2). The protein MFE-2 is one class of proteins in mammals catalyzing b-
oxidation. MFE-2 consists of three domains, the C-terminal domain shows similarities to 
sterol carrier protein type 2 (SCP-2) and is therefore referred to as a sterol carrier protein 2-
like (SCP-2L).6 The crystal structure of the SCP-2L protein (PDB 1IKT) displays a large apolar 
tunnel, which in this crystal structure contains a Triton X-100 molecule (Figure 1). SCP-2L is 
part of the superfamily of SCP-like, this is part of a class of proteins which were found to be 
involved in the biosynthesis of cholesterol. Their secondary structure is of particular interest 
as they often contain a hydrophobic binding pocket. The apolar tunnel seen within SCP-2L is 
of interest within ArM work because it can be used to direct substrates like hydrocarbons 
into the tunnel and provide more opportunity for substrate coordination to the protein’s 
secondary structure. This would allow the ArM’s to tailor or increase selectivity of a 
reaction. 
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Figure 1 – Ligand-modified Sterol Carrier Protein Type 2 like Domain (SCP-2L) PDB 1IKT 
forming a complex with Triton X-100. V83 and A100 are highlighted in yellow to show the 
placement of Cysteine when mutated. a) Space filled model to represent the apolar tunnel, 
b) Cartoon representation with Triton X-100 shown in grey c) Tunnel Dimensions 
 
In order to modify the selected protein template with our transition metal catalyst system, 
bioconjugation is carried out using a unique cysteine. Cysteine is an amino acid with a highly 
nucleophilic thiol function that is frequently exploited for site-selective bioconjugation.7 The 
presence of a unique cysteine is utilized to incorporate one transition metal binding ligand 
into the protein, at a unique position to benefit from the selective binding properties of the 
protein. In figure 1, the two amino acids V83 and A100 are highlighted as this is where 
unique cysteine residues have been previously introduced into the SCP-2L protein.3 Each 
mutant is introduced at either end of the large hydrophobic tunnel. Previous work also 
showed both mutants can be expressed in high yield and purification is straightforward.2  
 
The method of covalently attaching the designed maleimide-containing cofactor is achieved 
by utilizing the cysteine residue as a target (Scheme 1), this residue is a useful target 
because it has a high reactivity, due to its thiol group, but it also has a low abundance within 
a protein. The bioconjugation can be carried out using activated sulfides, a- halogen 
a) b)
c)
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carbonyls and maleimide functionalities. In this work we have concentrated on using the 
maleimide functionality.  
 
 
Scheme 1 – Selective Cysteine Modification using a) activated disulfides b) a- 
Halogencarbonyls c) Maleimide Functionality 
 
2.2 Cofactor Design and Synthesis 
2.2.1 Nitrogen containing ligand library 
The library of nitrogen containing cofactors depicted in Figure 2 was designed based on 
derivatives of known ligands, which have been successfully used in oxidation reactions with 
a variety of metals and substrates.8,9,10,11 This collection of cofactors has an array of useful 
properties including varied flexibility/ varied chain length from maleimide to metal ion and 
they also vary between bidentate and tridentate.  
 
Distefano et al. demonstrated the successful coupling of a phenanthroline moiety 
selectively to a unique cysteine residue within a protein using 5-iodoacetamide-1,10-
phenanthroline.12 Many other nitrogen donor ligands have been introduced via a site 
selective linkage to cysteine in a similar way.3, 13 
 
 
 
 
Protein-SH
R
S S
O
O
Protein S
S R
H S
O
O
X
O
R
S
O
R
Protein HX
NO
O
R
N
O
O
R
SProtein
a)
b)
c)
 22 
 
 
 
 
Figure 2 - The library of nitrogen containing cofactors 
 
2.2.2 Synthetic Route to Cofactor E 
 
The synthesis of this ligand has been previously reported in literature14 using a Mitsunobu 
reaction between maleimide and bis(picolyl)aminoethanol (Scheme 2). However, even with 
a large number of attempts varying the conditions, the synthesis could not be reproduced. 
 
 
Scheme 2 – Synthesis of Cofactor E via the Mitsunobu Reaction 
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In order to protect the maleimide functionality during reactions, it was reacted with furan 
under microwave conditions to create a stable Diels-Alder adduct. This Diels- Alder 
maleimide adduct (1) was isolated as the pure exo adduct as a protected Michael acceptor. 
This adduct was then applied to SN2 type reactions to yield the protected cofactor (3), which 
was then subjected to a retro Diels Alder to produce the final product (Cofactor E) (Scheme 
3). The overall yield is 25%, which is low mainly due to the troublesome step of addition of 
dipicolylamine. 
 
 
Scheme 3 – Synthetic Route to Cofactor E 
 
The other cofactors within the designed library were made by Dr Amanda Jarvis, Andrew 
Ward and Dr Peter Deuss from the Kamer Group.  
 
2.4 Protein expression and purification 
To acquire our desired protein, the gene of interest is cloned into a plasmid containing a 
cleavable histidine tag using TEV protease, and a specific antibiotic resistance. This plasmid 
is then transformed into a host cell; inthis work Escherichia coli (E. coli) Rosetta DE3 cells 
were used. This is the most common bacterial strain used to obtain protein in laboratory 
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conditions due to its fast growth rate, its relatively simple growth requirements, the 
simplicity of growing the organism, and the avirulent nature of laboratory strains. 
A number of cells harbouring the desired plasmid are used to inoculate a large volume of 
media. This media is a broth that contains sugars to feed the bacteria and the antibiotic the 
plasmid provides resistance to. Any cells that don’t contain the same antibiotic resistance 
will die as a consequence. Once the cells have grown to an optical density of 0.6 (600nm), 
the expression of the desired gene encoding the production of the desired protein is 
triggered. Protein expression is induced with isopropyl b-D-1- thiogalactopyranoside (IPTG); 
a molecular analogue of allolactose, a lactose metabolite that prompts transcription of the 
lac operon. IPTG binds to the lac repressor, which is then released from the lac operator in 
an allosteric manner, thereby allowing the transcription of genes in the lac operon. The lac 
operon is a working unit of genomic DNA under the control of a single regulatory signal or 
promoter, which is required for transport and metabolism of lactose in E. coli. (Figure 3). 
 
Figure 3 – Diagram representation of protein expression procedure. a) Plasmid containing 
desired gene and cleavable His Tag, b) Transformation of vector into bacterial cell, c) 
Inoculation of bacterial cell into media, d) Bacterial cells grow to a high optical density e) 
Protein expression induced by addition of IPTG 
 
Once protein is expressed, the cells were harvested by centrifugation, and the cells are 
disrupted by sonication. To aid cell lysis, lysozyme, deoxyribonuclease (DNase), and the 
protease inhibitor benzamidine were added to samples. Once the cells had been lysed, the 
soluble protein was isolated by centrifugation, as any insoluble cell debris would form a 
pellet and the supernatant could then be extracted and purified. The advantage of using a 
protein that contains a histidine tag is that this provides a very simple and effective 
purification method. The binding affinity of the six tandem histidine residues towards a 
nickel column can be utilised (Figure 4). The supernatant is applied to a Ni-column, only 
6x His
a) b) c) d) e)
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proteins with a high nickel affinity will be adsorbed and all other proteins will be washed 
out. Using an appropriate buffer containing a large excess of imidazole, the desired protein 
can then be eluted. The histidine tag can then be cleaved using TEV protease; a highly 
specific protease found in Tobacco Etch Virus (TEV). The residues ENLYFQG, introduced next 
to the His-tag, form the recognition sequence used and cleavage occurs between the 
glutamine and glycine residues.  
 
Figure 4 – His tagged Protein binding to a Nickel affinity column 
 
The initial runs of protein expression and purification produced very low yields, approx. 
2mg/ L as determined by Bradford assay. This is obviously not suitable to try and apply in 
catalysis work and thus required further optimization. The starting point was to increase the 
levels of DNase used, as an efficient lysis procedure is essential for high protein yields.  
Another step of the procedure that was looked at was the histidine tag cleavage, this 
reaction occurs by stirring the protein solution with TEV protease. Both SCP-2L mutants are 
prone to precipitation, so to try and increase the proteins stability in this reaction the 
protein used is kept in very dilute solution. Also, the reaction is stirred on the lowest 
possible setting to try not to agitate the protein solution. These alterations proved to be 
successful as both SCP-2L A100C and V83C were successfully produced and optimised to 
yield on average 60mg/ml and 40 mg/ml respectively. 
 
2.5 Protein Scaffold Modification 
2.5.1 General Methodology 
The scheme for modification of both SCP-2L A100C and V83C is carried out by covalent 
modification as previously described and is depicted in Scheme 4.  The reactive thiol group 
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of the unique cysteine residue within the protein scaffold, reacts with the maleimide 
functionality in the cofactor to modify the protein. Most ligands are not soluble in the 
aqueous conditions of the protein solution so these are added in minimal (50µl) amount of 
organic solvent. After modification, extensive buffer exchange using centrifugral 
concentrators is carried out to ensure there is no unbound ligand in the protein solution. 
One possible disadvantage of this modification technique is that a chiral carbon is formed 
during the reaction, which gives the possibility of the formation of different stereoisomers. 
This could be undesirable if the target application is asymmetric catalysis. However, it is 
possible that the chiral protein environment induces a preference for one of the 
stereoisomers.  
 
 
 
Scheme 4 –Modification of SCP–2L V83C with Cofactor E 
 
In order to form the ArM a complex must be formed, this is carried out by the addition of a 
metal salt to the nitrogen donor ligand modified protein. Once analysed, any excess metal 
ion must be removed to ensure that any catalysis carried out with the ArM is not being 
affected by any metal ions in solution. 
 
2.5.2 LCMS analysis 
 
For all of the reported nitrogen containing ligands the modification was seen to proceed 
with 100% conversion to afford the modified protein. To confirm this, LCMS analysis was 
carried out to see the increase in mass, an example of this is shown in Figure 5 using SCP-2L 
modified with Cofactor E. 
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SCP-2L A100C-E: 
Calculated mass: 13726.7 Da, Observed: 13727.1 Da.  
SCP-2L V83C-E: 
Calculated mass: 13698.7 Da. Observed: 13699.8 Da.  
Figure 5 – Deconvoluted mass spectrum showing the increase in signal upon modification for 
SCP-2L A100C-E  
The Abundance shown as a (%) on the y axis. 
 
Analysis of the ArM complex with a metal ion is very difficult by LCMS, as it is unknown if a 
signal can’t be seen of the complex whether this means the complexation was unsuccessful, 
or the mass spectrometry conditions caused removal of the metal ion. In one circumstance I 
successfully managed to see SCP-2L A100C- Cofactor Z- Cu2+ (Figure 6), but analysis by UV 
studies were carried out to get a better understanding of the ArM complexes. 
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Figure 6 – Mass Spectrum of SCP-2L A100C, modified with Cofactor Z, and then complexed 
with Cu2+ 
2.5.3 CD analysis 
 
CD spectroscopy measure differences in the absorption of left-handed vs right-handed 
polarized light, which occurs due to structural asymmetry. This tool is often used for protein 
structural studies, as it can give an indication how the protein is folded and can provide 
information about its secondary and tertiary structure.15,16,17 The CD spectrum in the near-
UV region (250-350nm) can provide some information about the proteins tertiary structure. 
The chromophores that are absorbed at these wavelengths are any aromatic residues and 
disulfide bonds.18 
 
The near UV CD spectra of SCP-2L V83C and A100C are compared to their spectrums when 
modified with Cofactor D (Figure 7). For both mutants a change in the near UV CD-spectrum 
is seen between the modified and unmodified proteins. It can be assumed from this that by 
modifying the protein with the cofactor the protein folding has slightly changed. However, 
the significant change in signal between 250 and 270nm is due to the introduction of 
pyridine rings into the protein.  
 
 
Figure 7 – CD Analysis of SCP-2L A100C and SCP-2L V83C and the modified proteins with 
Cofactor D 
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Interestingly, when the near UV CD spectrum of SCP-2L V83C was compared with its hybrid 
containing cofactor E (Figure 8), it showed very little changes in the folding pattern and the 
significant changes appear from the introduction of aromatic residues.  This is interesting as 
it suggests that Cofactor D and E are in different chiral environments when bound to SCP-2L 
mutants. 
 
 
Figure 8 – Near UV spectrum of SCP-2L V83C and the modified hybrid with Cofactor E. 
 
 
2.6 Determining concentration of Artificial metalloenzymes  
 
2.6.1 Concentration calculation using Bradford reagents 
 
Common methods to determine protein concentration are using the absorbance at A280 
from aromatic signals and also using Bradford Reagent.19 Quantifying protein concentration 
by directly measuring A280 is a fast and convenient method as no additional reagents or 
incubation periods are necessary.  Using the proteins extinction coefficient and the A280 it 
is possible to calculate a reliable value for the concentration using Beer’s Law.  
 
The alternative method is a Bradford protein assay, which is used to measure the 
concentration of total protein within a sample. The principle is that the binding of protein 
molecules to Coomassie dye under acidic conditions results in a colour change from brown 
to blue. An estimation is performed using a reference protein standard, generally bovine 
serum albumin (BSA) is the commonly accepted reference. However, if the reference 
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protein has very different properties to the protein in question then this method becomes 
unreliable.  
 
The modification of protein introduces new aromaticity into the structure and therefore, 
analysis was required to determine if normal methods of calculating protein concentration 
were reliable. In order to obtain reliable catalytic data using ArMs it is critical that the 
method used to determine the concentration of the ArM is accurate. Experimental analysis 
was carried out using SCP-2L A100C modified with a TPA cofactor (Cofactor D).  The initial 
task was to compare these two methods, to see if simply measuring concentration at A280 
using a nanodrop and using a Bradford protein assay gave comparable results. (Figure 9) 
Concentration using a nanodrop was calculated using the calculated extinction coefficient 
for SCP-2L A100C based on the protein sequence using ExPASy ProtParam tool. 
 
 
 
 
Concentration using NanoDrop 
Average from 4 repeats = 1.76 mg/ml 
 
Figure 9 – Comparison of Protein Concentration measurements of SCP-2L A100C TPA using 
A280 with a nano drop and using a Bradford protein assay 
 
When using the ArM in catalysis it is crucial that we know the accurate concentration of the 
protein so further investigation was required to determine which method was giving the 
more reliable value. 
 
SCP-2L A100C TPA 
 OD595 OD595 
-Blank 
Calculated 
Concentration 
(mg/ml) 
Repeat 1 1.12 0.84 1.68 
Repeat 2 1.13 0.85 1.71 
Repeat 3 1.13 0.84 1.69 
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2.6.2 QAA analysis 
 
Quantative Amino Acid Analysis (QAA) is known as the gold standard analysis for accurate 
quantitation of proteins and peptides.20 It is a fundamental biochemical technique used for 
the determination of the amino acid composition of proteins, peptides and samples that 
contain primary or secondary amino groups within their molecular structure. We submitted 
the protein sample SCP-2L A100C TPA for QAA analysis at PNAC Facility, University of 
Cambridge. The results for the same sample previously studied showed an average from 
two repeats of 1.47mg/ml.  
 
The QAA results showed that using Bradford technique is not a suitable method to 
determine concentration of modified proteins. We therefore, calculated the extinction 
coefficient of the sample used for QAA analysis using the obtained concentration and 
compared this to calculated extinction coefficients for the modified protein. The calculated 
extinction coefficient was calculated by combining the theoretical extinction coefficient for 
the protein based on its sequence (Calculated using Protparam), with the extinction 
coefficients of the synthesised cofactors. 
 
Computed Extinction coefficient at A280 for SCP-2L is 13980 M-1 cm-1 
Experimentally determined Extinction coefficient at A280 for TPA is 1247.5 M-1 cm-1 
SCP-2L A100C TPA Extinction coefficient at A280 by addition is 15227.5 M-1 cm-1 
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Using the SCP-2L A100C TPA the extinction coefficient at A280 was experimentally calculated 
as 15044 M-1 cm-1 
 
Nanodrop value readjusted with experimental extinction Coefficient (15044 M-1 cm-1) is 1.56 
mg 
Nanodrop value readjusted with calculated extinction Coefficient (15227 M-1 cm-1) is 1.54mg 
 
The calculated and experimental extinction coefficients are within error, and both of them 
are within 5% of the concentration obtained by QAA analysis. Therefore, for all the work 
reported the concentrations were determined by A280 using the calculated extinction 
coeffients given below. (Table 1) As cofactor C does not absorb significantly at 280 nm, the 
calculated extinction coefficient of the protein was used.  This experiment was the repeated 
for all of the cofactors moving forwards. 
 
 Synthesised Cofactor Modified Protein 
Cofactor Extinction Coefficient (M-1 cm-1) Extinction Coefficient (M-1 cm-1) 
X 2769 16749 
Y 1043 15023 
Z 16744 30724 
D 1247.5 15227 
E 384 14364 
Table 1 – Extinction Coefficient values of modified proteins 
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2.7 Metal Binding Studies of Artificial metalloenzymes 
 
UV studies have been widely used for protein analysis and also within artificial 
metalloenzyme work.2, 21, 22 To determine if the metal binds to the modified metalloenzyme 
in a 1:1 ratio as designed, UV analysis was used. Equivalents of the metal salt are added 
gradually, and the UV spectrum is recorded at each point to determine the saturation point. 
 
The saturation plot for both SCP-2L A100C and V83C hybrids with Cofactor D show that the 
Fe(Otf)2.2MeCN metal ion appears to bind in a 1:1 ratio with the protein (Figure 10). After 
1.0 equivalent of metal ion is added to the ArM both plots level out, showing it has reached 
its binding capacity. 
 
SCP-2L A100C -Cofactor D                                           SCP-2L V83C -Cofactor D  
Figure 10– Saturation plot of SCP-2L A100C and V83C modified with cofactor D with 
Fe(Otf)2.2MeCN 
 
The saturation plot for both SCP-2L A100C and V83C hybrids with Cofactor E also indicated a 
1:1 binding with Fe(Otf)2.2MeCN. (Figure 11) However, in this instance it appears the 
absorbance at 400nm continues to increase till 1.1 equivalents of metal were added before it 
reached full binding capacity. This could also indicate a relatively low binding constant.  
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SCP-2L A100C -Cofactor E                                           SCP-2L V83C -Cofactor E                                          
 
Figure 11 – Saturation plot of SCP-2L A100C and V83C modified with cofactor E with 
Fe(Otf)2.2MeCN 
 
The binding capacity of Fe(Otf)2.2MeCN with both hydrids of SCP-2L A100C and V83C with 
Cofactor Z is significantly greater than 1:1, the absorbance continued to increase past 1.5 
equivalents (Figure 12). This was also pushed all the way up 3 equivalents and still no 
saturation was seen, this could be due to a very low binding constant. 
 
SCP-2L A100C -Cofactor Z                                           SCP-2L V83C -Cofactor Z                                          
 
 
Figure 12 – Saturation plot of SCP-2L A100C and V83C modified with cofactor Z with 
Fe(Otf)2.2MeCN 
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Both Cofactor X and Y hybrids showed similar results when bound with Fe(OTf)2.2MeCN  
(Figure 13). It can be seen in both circumstances that the ArM does reach binding capacity. 
For Cofactor X, it appears to take 1.2 equivalents of metal ion until the hybrid protein has 
reached saturation point. For Cofactor Y, it has increased further and requires 1.4 
equivalents of metal ion until it reaches capacity. This could also be a result of a poor 
binding constant, resulting in the requirement of excess of metal to drive the equilibrium to 
completion.   
 
SCP-2L A100C -Cofactor X                                          SCP-2L V83C -Cofactor X                                         
 
 
SCP-2L A100C -Cofactor Y                                          SCP-2L V83C -Cofactor Y  
Figure 13 – Saturation plot of SCP-2L A100C and V83C modified with cofactor X and Y with 
Fe(Otf)2.2MeCN 
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2.8 Conclusions and Further Work  
 
In this chapter the successful synthesis of an array of ArMs, based upon SCP-2L protein 
scaffold and a nitrogen containing ligand library, has been shown. It is of great importance 
when using the ArM in catalysis to know the exact modified protein concentration. Using QAA 
analysis and UV studies to experimentally calculate extinction coefficients, an accurate 
method was successfully determined. 
 
LCMS studies of ArM systems showed most metals are only weakly coordinated to the 
modified protein and are destroyed during LCMS conditions. UV and CD analysis provided 
insight into the protein scaffold structure and how it is affected by modification with a 
synthetic cofactor. By creating a saturation plot using UV, the binding nature of the metal to 
protein was studied and identified which ArM systems showed a 1:1 binding as designed. 
 
Analysis carried out by LCMS, UV and CD can give us a good understanding of the ArM, but in 
order to have greater knowledge a crystal structure of the modified protein and/or complex 
should be obtained. While this was attempted no success was seen, so further optimisation 
of crystallisation methods should be studied to gain structural information about the ArM.  As 
an alternative the protein scaffold could be isotopically labelled by cultivation in a medium 
containing N15 as the only source of nitrogen. NMR methods could then be used to gain 
structural information about the modified protein. If structural characterisation of the 
modified protein was obtained, then it could be used to model future ArMs. It would provide 
an insight into the structural properties next to the introduced cofactor and fine-tune this 
active site, and the coordination site of the metal. 
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2.9 Experimental 
2.9.1 General Remarks  
 
All reagents and solvents were obtained commercially and used without further purification. 
nBuLi was titrated against 2-3 dimethoxybenzyl alcohol prior to use to determine the 
correct concentration. Thin layer chromatography was performed on silica plates (TLC silica 
gel 60 F254 Merck) and visualised with UV light (254 nm). Column chromatography was 
performed using silica gel 60 particle size 40-63 μm from Merck. NMR spectra were taken at 
room temperature with Bruker Avance 300, 400 or 500 NMR spectrometers. Chemical shifts 
(δ) are given (in ppm) and processed using MestReNova software. The residual 
undeuterated solvent of the deuterated solved (CHCl3 δ = 7.26 and 77.16, 1H and 13C 
respectively) was used to reference the chemical shifts. The abbreviations for the 
multiplicity of the proton, carbon and fluorine signals are as follows: s singlet, d doublet, dd 
doublet of doublets, ddd doublet of doublet of doublets, t triplet, dt double triplets, q 
quartet, m multiplet, br s broad singlet.  
 
Circular dichroism spectra were obtained using a Biologic MOS-500 spectrometer. A Xe lamp 
was used, and the near UV spectra were taken from 190 – 260 nm using a 10 mm 
pathlength cell.   
 
Protein images were processed by Pymol 0.99rc6.  
 
LC-MS used for analysis of protein was performed on a Waters Alliance HT 2795, equipped 
with a Micromass LCT-TOF mass spectrometer using positive electrospray ionisation and 
applying a Waters MASS PREP On-line desalting 2.1 x 10mm cartridge. ESI results were 
analysed by Mass Lynx V 4.0 and its MaxEnt algorithm.  
The following MS-tune settings were used for both LC-MS and direct injection: Capillary = 
3000 V, Sample Cone = 50 V, Extraction Cone = 3 V, RF Lens = 350, Dessolvation 
Temperature = 300 °C, Source Temperature = 100 °C, RF DC Offset 1 = 10, RF DC Ofset 2 = 8, 
Aperture = 10, Acceleration = 200, Focus = 0, Steering = 0.0, MCP Detector = 2850, Manual 
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Pusher = Yes, Max. Flight time = 70, Ion Energy = 32, Tube Lens = 0, Grid 2 = 60, TOF flight 
tube = 4600, Reflection = 1788.  
 
The gradient used for LCMS protein analysis is shown in Table 2 below. 
Time (min) Solvent A (%) Solvent B (%) Flow (ml/min) 
0.0 2 98 0.05 
0.5 2 98 0.05 
2.5 98 2 0.05 
4.5 98 2 0.05 
4.6 2 98 0.05 
12 2 98 0.05 
Table 2 – Gradient used for LCMS analysis. Solvent A = 1% formic acid in acetonitrile, Solvent 
B = 1% formic acid in water. 
 
Buffer exchange for protein was carried out using centrifugal concentrators with a 
molecular weight cut-off of 10 kDa.  
The pH of buffers were adjusted using aqueous solutions of sodium hydroxide or 
hydrochloric acid.  
 
2.9.2 Synthesis of Cofactor E 
Step 1: Synthesis of (3aR,4S,7R,7aS)-3a,4,7,7a-tetrahydro-1H-4,7-epoxyisoindole-1,3(2H)-
dione (i) was carried out according to literature.23 
 
 
 
 
Mp-160-161 °C 
A mixture of maleimide (0.855 g, 1 equiv., 8.8 mmol), furan (1.1 mL, 1.7 equiv., 15 mmol) 
and H2O (10 mL) was heated in a 35 mL microwave reaction vessel to 90 °C (100 W) for one 
hour. The flask was left to cool and a white crystalline solid was precipitated and filtered, 
then washed with diethyl ether and dried under vacuum to afford the product as white 
crystalline solid. (4.83 g, 84%) yield. 
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1H NMR (300 MHz, CDCl3) δ 7.98 (br s, 1H, NH), 6.46 (t, J = 2.9 Hz, 2H, Ha,b), 5.25 (t, J = 2.9 
Hz, 2H, Hc,h), 2.83 (s, 2H, Hd,g). 
 
Step 2: (3aR,4S,7R,7aS)-2-(2-bromoethyl)-3a,4,7,7a-tetrahydro-1H-4,7-epoxyisoindole-
1,3(2H)-dione (ii)carried out according to literature24. 
 
 
 
Under an argon atmosphere, a solution of furan protected maleimide (1.5g, 1 equiv, 
9.08mmol), 1,2 dibromoethane (3.94ml, 5 equiv, 45.4mmol) and K2CO3 (6.27g, 5 equiv, 
45.4mmol) in DMF (90 mL) was stirred at 50 °C overnight. The reaction was monitored by 
TLC analysis and upon completion, the solvent was removed under reduced pressure. Ethyl 
acetate (600 mL) was added to the reaction mixture and the product was extracted using 
water (4 x 300 mL). The organic fractions were combined and dried over MgSO4. The 
product was filtered, concentrated and purified by column chromatography (2%MeOH : 
DCM) to give an off white solid (0.9g, 38% yield). 
1H NMR (300 MHz, CDCl3) δ 6.60 – 6.43 (m, 2H, Ha,b), 5.37 – 5.18 (m, 2H, Hc,j), 3.88 (t, J = 6.9 
Hz, 2H, Hf), 3.47 (t, J = 6.9 Hz, 2H, Hg), 2.88 (s, 2H, Hd,i). 
 
Step 3: Synthesis of bis(picolyl)aminoethylmaleimide-furan protected (iii) 
 
 
 
 
 
In a 250ml Schlenk flask, dipicolylamine (1.23ml, 1 equiv, 6.83mmol), maleimide tether (ii) 
(1.85g, 1 equiv, 6.83mmol), triethylamine (0.95ml, 1 equiv, 6.83mmol) and potassium iodide 
(1.13g, 1 equiv, 6.83mmol) were added to acetonitrile (90ml) under argon. The reaction 
mixture was stirred under argon at 70 °C for 72 hours. When the reaction had reached 
completion according to TLC analysis (eluent Ethyl Acetate: Hexane 3:1), water (100ml) was 
added and then the product was extracted with ethyl acetate (3 x 100ml). The organic 
fractions were combined, dried over MgSO4 and concentrated. The product was purified by 
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column chromatography (10% Methanol: Dichloromethane) and the product isolated was a 
light brown oil and was isolated in a 35% yield. 
1H NMR (500 MHz, CDCl3) δ 8.52 (ddd, J = 5.0, 1.8, 1.0 Hz, 2H, Hs,m), 7.65 (td, J = 7.6, 1.8 Hz, 
2H, Hk,q), 7.48 (dt, J = 7.8, 1.1 Hz, 1H, Hj,p), 7.16 (ddd, J = 7.6, 5.0, 1.0 Hz, 1H, Hl,r), 6.53 (t, J = 
0.9 Hz, 1H, Ha,b), 5.26 (t, J = 1.1 Hz, 4H, Hc,v), 3.85 (s, 4H, Hh,n), 3.67 (t, J = 6.3 Hz, 1H, Hf), 3.49 
(s, 2H, Hd,u), 2.80 (t, J = 6.3 Hz, 2H, Hg). 
 
Synthesis of bis(picolyl)aminoethylmaleimide (iv)- Cofactor 1 
 
 
 
 
 
 
 
The bis(picolyl)aminoethylmaleimide-furan protected (iii) (0.13g, 0.34mmol) was dissolved 
in xylene (25ml). The reaction mixture was distilled to remove all traces of furan, upon 
boiling the thermometer reached a temperature of 49 °C before decreasing. The solvent 
was removed under reduced pressure. The crude product was recrystallized from 
ethanol/hexane (50:50). The product isolated was a light brown oily solid and was produced 
quantitatively. 
1H NMR (500 MHz, CDCl3) δ 8.53 (d, J = 5.1 Hz, 2H, He,l), 7.65 (t, J = 7.7 Hz, 2H, Hc,j), 7.42 (d, J 
= 7.9 Hz 2H, Hb,i), 7.17 (t, J = 5.1 Hz, 2H, Hd,k), 6.68 (s, 2H, Hp,q), 3.87 (s, 4H, Hf,g), 3.70 (t, J = 
6.1 Hz, 2H, Hn), 2.80 (t, J = 6.1 Hz, 2H, Hm). 
13C NMR (126 MHz, CDCl3) δ 170.6 (Co,r), 158.9 (Ca,h), 149.3 (Ce,l), 137.0 (Cc,j) , 135.2 (Cp,q), 
123.2 (Cb,i), 122.2, 60.0 (Cf,g), 51.5 (Cm), 35.8 (Cn). 
 
Spectral data correspond to those given in literature14 
HRMS (ESI) m/z [MH]+ 323.1503 (calculated C18 H18 N4 O2 H: 323.1503) 
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2.9.3 Protein Production and Purification of SCP-2L A100C & V83C 
 
SCP-2L A100C was prepared by transforming the pEHISTEV::dΔhΔSCP-2L A100C plasmid into 
competent E. coli Rosetta(DE3) cells. A single transformed colony was inoculated into 10 mL 
PB medium (Production Broth medium; containing 20 g/L tryptone, 10 g/L yeast extract, 5 
g/L dextrose, 5 g/L NaCl, 8.7 g/L K2HPO4, pH 7.0) with 50 μg/mL kanamycin and 34 μg/mL 
chloramphenicol (in ethanol). This was used to inoculate 100 mL PB media (50 μg/mL 
kanamycin and 34 μg/mL chloramphenicol) and agitated at 37 °C, 200 rpm overnight (16-18 
h).  This starter culture (10 mL) was used to inoculate 0.5 litre of PB medium (2 litres in 
total). The cells were allowed to grow at 37 °C to an OD600 of 0.6 (about 2 h) after which the 
temperature was lowered to 16 °C. Isopropyl-1-thio-β-D-galactopyranoside (IPTG) was 
added after one hour to a final concentration of 0.2 mM from a 0.2 M stock solution to 
initiate the expression of the recombinant protein. The culture was left overnight at 16 °C 
(16-18 h). The cells were harvested by centrifugation (20 min, 7500 g), washed with 250 mL 
of buffer solution (16 mM kPi (potassium phosphate) 120 mM NaCl, pH 7.4) and centrifuged 
again (20 min 7500 g). The pellet from the 2 litre cell culture was resuspended at 4 °C in 100 
ml of buffer solution (50 mM Tris·HCl, 20 mM imidazole, 150 mM NaCl, 0.5 mM 
benzamidine, pH 8) and frozen at -80 °C.  
 
After defrosting, 20 mg of lysozyme, 1 mg of DNase and 1 mL of 1 M of MgCl2 was added to 
the suspension. The suspension was left for 1 hour at 4 °C and was sonicated in portions of 
10 mL (Hielscher UP200S ultrasonic processor, 0.5 s pulses 90% power) with 0.5 second 
pulses for 1 minute. The cell-extract, obtained after centrifugation (50 min, 30000 g) was 
filtered (0.22 μm PES Millex Filter unit) and applied to a nickel column (5 mL HisTrap FF) 
equilibrated with 30 mM Tris·HCl, 20 mM imidazole, 150 mM NaCl, pH 8 (wash buffer) at 
flow rates up to 5 mL/min. The column was washed with 5 column volumes of wash buffer, 
5 column volumes of high salt buffer (wash buffer containing 1 M NaCl) and another 5 
column volumes of wash buffer. The protein was obtained by eluting with 6 column 
volumes elution buffer (wash buffer containing 330 mM imidazole) into an equal volume of 
wash buffer to prevent precipitation of the protein and the resulting solution was dialysed 
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against 5 litre buffer solution (30 mM Tris·HCl, 10 mM imidazole, 150 mM NaCl, pH 8 at 4°C). 
If precipitate had formed the resulting mixture was centrifuged (30000 g, 50 min). 0.014 
equivalents of TEV-protease25 and final concentrations of 1 mM DTT and 0.5 mM EDTA were 
added to resulting His-tagged SCP-2L A100C solution. This mixture was left overnight at 
room temperature. 
 
If precipitate had formed the mixture was again centrifuged (50 min, 30000 g) and the pellet 
was discarded. The supernatant was then filtered (0.22 μm PES Millex Filter unit) and used 
for nickel affinity chromatography on a nickel column (5 mL HisTrap FF) equilibrated with 
wash buffer. The flow-through containing pure SCP-2L A100C was collected, concentrated 
and the buffer was exchanged to the storage and coupling buffer (20 mM MES, 50 mM NaCl, 
pH 6) using a centrifugal concentrator. Three consecutive rounds of buffer exchange were 
performed to remove all the DTT. Buffer exchange by centrifugal concentrator was found to 
be more effective than dialysis.  Yields up to 75 mg L-1 culture, with a purity of more than 
>99% according to SDS-PAGE (Nupage™ 4-12% Bis-Tris gel), were obtained.  
 
2.9.4 Bioconjugation of cofactor to unique cysteine mutants of SCP-2L 
 
A 25-50 μM solution of protein in buffer (20 mM MES 50 mM NaCl pH 6) was incubated with 
10 equivalents cofactor added from a 50 mM stock solution in the corresponding buffer. 
Typically, no residual free protein was observed.  The reaction mixture is shaken gently and 
left at room temperature overnight. When full conversion was shown the mixture was 
washed using a centrifugal concentrator with buffer to remove the excess cofactor.  
 
2.9.5 Deconvoluted Mass Spectrums of Modified Proteins. 
 
LC-MS(ES+) used for analysis of protein and conjugation-reactions was performed on a 
Waters Alliance HT 2795 equipped with a Micromass LCT-TOF mass spectrometer, using 
positive electrospray ionisation and applying a Waters MASSPREP® On-line Desalting 2.1x10 
mm cartridge using a gradient of 1% formic acid in H2O to 1% formic acid in acetonitrile. ESI-
MS results were analysed by MassLynx V. 4.0 and its MaxEnt algorithm. The spectrums 
shown are deconvoluted and the y axis is given in % abundance.  
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SCP-2L V83C-Z: 
Calculated mass: 13652.6 Da, Observed: 13652.1 Da.  
 
SCP-2L A100C-Z: 
Calculated mass: 13679.7 Da, Observed: 13680.9 Da.  
 
 
 
 
 
 
 
 
 
 
SCP-2L V83C-Y: 
Calculated mass: 13727.7 Da, Observed: 13727.0 Da.  
 
SCP-2L A100C-Y: 
Calculated mass: 13754.7 Da, Observed: 13756.1 Da.  
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SCP-2L A100C-E: 
Calculated mass: 13726.7 Da, Observed: 13727.1 Da.  
SCP-2L V83C-E: 
Calculated mass: 13698.7 Da. Observed: 13699.8 Da.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCP-2L A100C-D: 
Expected mass: 13803.8 Da, Observed: 13805.0 Da.  
SCP-2L V83C-D: 
Calculated mass: 13775.8 Da, observed: 13775.2 Da.  
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SCP-2L V83C-C: 
Calculated mass: 13656.8 Da, Observed: 13656.0 Da.  
SCP-2L A100C-C: 
Calculated mass: 13684.8 Da, Observed: 13684.5 Da.  
 
 
 
 
 
 
 
 
SCP-2L V83C-X: 
Calculate mass: 13748.7 Da, Observed: 13748.5 Da.  
SCP-2L A100C-X: 
Calculate mass: 13776.7 Da, Observed: 13777.1 Da.  
 
 
 
 
 
 
 
 
 
 
2.7.5 Determination of Modified Protein Concentration 
QAA analysis was carried out PNAC facility, Dept of Biochmistry, University of Cambridge 
and the full detailed set of results are shown below. 
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Sample: AA1    Sample: AA2   
Integer fit of measured mole ratios to expected values  Integer fit of measured mole ratios to expected values 
 Expected  Closeness of fit   Expected  Closeness of fit 
Amino acid value Observed value to expected value  Amino acid value Observed value to expected value 
Cys 1 not determined -  Cys 1 not determined - 
Asp 10 10.22 better than 5%  Asp 10 10.20 better than 5% 
Thr 5 5.06 better than 5%  Thr 5 5.11 better than 5% 
Ser 6 5.81 better than 5%  Ser 6 5.91 better than 5% 
Glu 12 11.83 better than 5%  Glu 12 11.74 better than 5% 
Gly 15 14.27 better than 5%  Gly 15 14.33 better than 5% 
Ala 8 8.13 better than 5%  Ala 8 8.00 better than 5% 
Val 8 7.60 better than 5%  Val 8 7.61 better than 5% 
Met 4 3.94 better than 5%  Met 4 4.02 better than 5% 
Ile 9 8.55 better than 5%  Ile 9 8.55 within 5-10% 
Leu 11 11.13 better than 5%  Leu 11 11.09 better than 5% 
Norleu std        Norleu std       
Tyr 2 2.11 within 5-10%  Tyr 2 2.08 better than 5% 
Phe 6 6.57 within 5-10%  Phe 6 6.56 within 5-10% 
His 1 1.09 within 5-10%  His 1 1.09 within 5-10% 
Lys 15 15.38 better than 5%  Lys 15 15.37 better than 5% 
Arg 4 4.29 within 5-10%  Arg 4 4.34 within 5-10% 
Pro 0 excluded -  Pro 0 excluded - 
Trp 2   (not determined)  Trp 2   (not determined) 
Total  (used) 116 residues    Total  (used) 116 residues   
   Average AA1,2      
Total sample 2.647 nmoles 2.665  Total sample 2.682 nmoles  
 36.55 ug 36.79   37.03 ug  
Concentration 52.95 nmoles/ml 53.30  Concentration 53.65 nmoles/ml  
 730.94 ug/ml 735.78   740.61 ug/ml  
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Chapter 3 – Engineering thermo stability in SCP-2L to increase catalytic activity for 
hydroformylation  
 
3.1 Introduction to protein engineering 
 
Over the last decades, the power of biocatalysis in chemical synthesis, particularly within an 
industrial setting, has become undeniable. Enzymes such as transaminases and 
ketoreductases are increasingly used in the synthesis of chiral intermediates in 
pharmaceutical processes1,2,3 showing that biocatalytic technology may replace chemical 
steps as part of existing chemical pathways by its simple nature and attractive sustainability 
metrics. The recent work towards artificial metalloenzymes (ArMs) has added to the potential 
of biocatalysis, and provides an elegant approach to combining enzymatic and chemical 
methods, with the potential to create novel  catalysts.4,5,6,7  ArMs combine the molecular 
recognition properties of enzymes, which are responsible for the high selectivities observed 
in many enzymatic processes, with synthetic transition metal cofactors allowing unnatural 
reactions to be introduced into the biocatalysis arena. The most successful method to create 
ArMs has been non-covalent binding utilizing protein scaffolds with supramolecular 
recognition motifs e.g. (strept)avidin.8 The inclusion of a cofactor within the protein scaffold 
can also be achieved by covalent modification using a free thiol group on a unique cysteine 
residue. Using these methods, a whole range of ArMs have been developed for unnatural 
reactions including transfer hydrogenation9, hydroformylation,10 cross coupling reactions and 
other carbon-carbon bond forming reactions such as the Diels-Alder reactions.11   
 
Whilst the use of proteins and enzymes in industrial processes has become increasingly 
common, the combination with organometallic cofactors can be difficult as the conditions 
they require for efficient catalysis can include high temperatures and the presence of organic 
solvents. Enzymes have evolved over time to work in a cellular environment; therefore, harsh 
conditions often lead to denaturation of proteins and deactivation of the catalyst.12 This is a 
particular problem in transferring chemical reactions into biocatalytic reactions as ArMs are 
designed to do. Several successful examples showed that by targeting a protein using 
computational methods, the stability of the protein could be improved, which in turn can 
demonstrate higher reactivity.13, 14 Based on these documented examples we hypothesized 
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that if we could increase the thermostability of the protein scaffold, we could increase the 
activity of our hybrid catalysts and their tolerance to organic solvents.15 This would expand 
the repertoire of possible reactions we could conduct and increase the experimental design 
space we can operate in. 
 
The strategy used to engineer thermostability into a protein is the rational design of 
mutations based on structural information.  Such mutations can be focused on flexible regions 
in the protein with the aim to reduce flexibility.16 Introducing disulphide bridges can stabilize 
early unfolding regions or destabilize the unfolded state by reducing its entropy.17 However 
within ArM work introducing disulphides is not applicable as it could result in multiple 
coordination sites for protein modification. Another strategy to enhance stability is the 
introduction of surface-located charged groups that can form salt bridges.18  The electrostatic 
interaction contributes to the stability of the protein, so it would be beneficial to introduce 
this into flexible regions within the proteins scaffold.19 Several studies show that modifying 
electrostatic interactions, such as removal of isolated surface charges20, 21 contribute to the 
stability of the protein. Analysis of the superfamily, that the protein in question belongs to, 
can also be utilised to identify any consensus sequences that could be introduced or adjusted 
to benefit the protein. The consensus approach is based on the hypothesis that the more 
highly conserved amino acids of a sequence alignment generally add more to the protein than 
the non-conserved amino acids.22 
 
The Kamer group has previously reported covalent approaches for synthesizing ArMs 
containing metal binding ligands via a maleimide linker to the protein scaffold human steroid 
carrier protein SL (SCP-2L).23 The SCP-2L protein is a domain from the multifunctional enzyme 
type 2 (MFE-2) and was specifically selected for its ability to bind linear substrates in its 
hydrophobic tunnel.24 This hybrid catalyst showed high activities and selectivities for the 
production of long chain linear aldehydes in rhodium-catalyzed hydroformylation of alkenes, 
under benign aqueous conditions (Scheme 1).25 This reaction is of industrial interest due to 
the high added-value of the aldehyde products in comparison to the alkene substrates.   
Within industry, rhodium-catalyzed hydroformylation is used on a large scale under biphasic 
conditions, enabling the recovery of the expensive rhodium catalyst. However, this reaction 
is challenging for longer alkenes (>5 carbon atoms) due to their low solubility in aqueous 
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solution. 26  ArMs provide a catalyst for higher alkene substrates that can work at low 
temperatures compared to industrial conditions (typically 110-120 °C), with high selectivity 
and turnover numbers, overall providing a much greener reaction.  We set out to see if we 
could use sequence-based / rational protein engineering techniques to increase the stability 
of our artificial hydroformylase and thus potentially increase the reaction temperature and, 
therefore, rate of hydroformylation.   
 
 
Scheme 1. Hydroformylation of alkenes to aldehyde products. Conditions from previous work 
within the Kamer group.10 
3.3 Design of thermostable mutants 
 
The design of mutations that could increase stability of SCP-2L was carried out both using 
rational design and sequence based mutant selection with SCP-like family 3DM database.27 
The 3DM databases consist of structure-based alignments of homologous sequences and 
assigns each residue a position number that allows comparison of positions that are 
conserved in the protein sequence. Novel crystal structures of the SCP-2L variants with a 
cysteine residue introduced for covalent bonding (SCP-2L variants A100C and V83C) were 
added to the SCP-like family database. Using the 3DM database and structural analysis of the 
protein, the positions in the protein where mutations towards consensus could likely be 
introduced without loss of structural integrity were determined (Figure 1). The consensus 
sequences are the most likely residues found at a specific position within the protein super 
family. Therefore if SCP-2L was missing any of the consensus residues they would be an 
interesting target to be introduced. The hydrophobic tunnel, which could be involved in ligand 
binding, was excluded from mutagenesis, as were the four helices that are involved in 
H
O
H
O
linear, 1
branched, b
CO/H2 1:1
80 bar
MES 50 mM
NaCl 20 mM
pH 6.0, 35 °C
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substrate binding, i.e. long-chain fatty acyl-CoAs28 and cholesterol derivatives.29 Mutations 
were especially sought in three loops that appear more flexible based on the B factor of the 
structure. 
 
 
 
 
 
 
 
Figure 1.  SCP-2L (1IKT) Mutation points to consider and avoid, highlighted in red are areas to 
avoid and in green are the areas that could be of interest. 
 
To stabilize the protein, I evaluated a number of rational mutation strategies, including 
stabilizing the flexible loop regions by salt bridge formation, strengthening alpha helix dipoles 
and to mutations introducing conserved amino acids in the target protein. The first step of 
the design process was to identify residues that would lead to the formation of salt bridges 
to stabilize the flexible loops and regions on the proteins surface.  I44 is positioned within a 
loop between beta sheets in a flexible region so creating a salt bridge here was anticipated to 
help increase stability. I44 is in close proximity to a positively charged Lys residue and by 
introducing a Glu or Asp an electrostatic interaction can be introduced (Figure 2). Residues 
S56, K58, K65 and E81 were also identified as sites for salt bridge formation, which can be 
achieved by reversing / or introducing a charge to create new ionic interactions. 
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Figure 2. Introduction of a possible Glu44-Lys47 salt bridge by mutation I44E. 
 
The alignment of dipoles of the polypeptide backbone parallel to the axis of an alpha helix 
causes a net dipole moment with its positive pole at the amino terminus and negative pole at 
the carboxy terminus. Residue N31 is found on the terminus of an alpha helix and to 
strengthen the helix dipole a charged residue was introduced by mutation N31D. 
Identifying amino acids that are highly conserved within the protein superfamily using the 
3DM database enables introduction of more conserved residues within SCP-2L. Residue V26 
is positioned within an alpha helix and is 15.5% conserved within the SCP-like 3DM database. 
However, F26 is the more abundant residue within the whole protein family (27.5% 
conserved). Furthermore, introduction of an aromatic residue at this position may provide 
potential π-stacking interactions (Figure 3). A residue that follows the protein super family’s 
consensus can also be introduced by mutations G41X, S54X, D116X and P68X. A full list of the 
designed mutants is shown in Table 1.  
 
 
Figure 3. Amino acid distribution for residue V26 within the SCP-like family in 3DM database 
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3.4 Synthesis of mutant library 
 
Site directed mutagenesis30 was performed both for SCP-2L A100C and V83C to separately 
obtain plasmids encoding mutations G41D, S56D, K58E, K58D, I44E, I44D, E81K, S54N, S56E, 
D116K, I44D, K40N, A68P, K65E, N31D, or V26F. Successful mutagenesis was seen for all of 
the designed mutants and this was determined by DNA sequencing. 
 
3.5 Thermostability testing of mutant library 
3.5.1 Thermofluor analysis of proteins 
 
One of the most common and convenient methods to measure the thermostability of a 
protein is to use a thermofluor assay. The thermofluor assay is a quick, temperature-based 
assay to assess the stability of the protein. The assay uses a Sypro Orange Dye (Figure 4) and 
is mixed with the target protein. The dye binds to the hydrophobic patches/ denatured 
protein and fluoresces. With increased temperature the protein denatures and unfolds, and 
it is therefore possible to monitor the increase in fluorescence signal and determine a melting 
temperature. This method was attempted on the SCP-2L mutants but proved to be 
unsuccesful. Due to the large hydrophobic tunnel within the protein, the dye binds 
immediately to protein and from time point zero a large signal was seen. Due to the initial 
large fluorescent signal, differences from protein unfolding were difficult to determine, 
therefore an alternative method was used. 
 
Figure 4 – Sypro orange Dye 
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3.5.2 Using CD spectroscopy to determine thermostability of protein scaffolds 
 
Using circular dichroism (CD) spectroscopy an approximate Tm,app31 was measured and 
compared to SCP-2L A100C and V83C encoded by the original plasmid. The CD method used 
a fast scan approach only measuring 6 different temperature points; therefore the Tm,app 
values are approximate and serve the purpose of indicating how the thermostability is 
affected by the new amino acid introduced. If the folding of the protein would be reversible 
then true thermodynamic parameters could be calculated. In this circumstance some 
precipitate is formed at higher temperatures, so the value given is Tm,app. However, this still 
gives information about the relative stability.  
 
The results showed some significant improvements in thermostability over the original SCP-
2L A100C and V83C proteins with increases of up to 12 and 10 °C observed for mutants 
constructed in an A100C and V83C background, respectively. In general, the A100C protein 
template was more responsive to the designed mutations. The introduction of N31D gave an 
increase of 12 °C for A100C, but only a 3 °C increase for V83C (Table 1, entry 1). The 
introduction of salt bridges was successful in raising the Tm,app of both mutants, with both 
E81K and S56D giving large increases in Tm,app. The Tm,app of mutant A100C increased by 9 
and 11 °C for E81K and S56D, respectively, and with V83C increases of 6 and 10 °C  were 
observed (Table 1, entries 4, 10). Mutation S56D improved the Tm,app in both mutants 
whereas S56E led to a decrease in Tm,app for both mutants. Introducing more conserved 
amino acids based on the results found using the 3DM database led to more modest increases 
in Tm,app. An exception was the G41D mutation in A100C which increased the Tm,app by 7 °C. 
In comparison, this mutation in V83C led to a decrease in Tm,app of 6 °C  (Table 1, entry 14). 
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Reaction 
Entry 
Design Method Mutation 
Template 
A100C V83C 
ΔT ( °C ) ΔT ( °C ) 
1 
Stabilizing α-helices 
dipole 
N31D 12 3 
2 
Introducing a salt 
bridge 
I44D 2 -1 
3 I44E 4 1 
4 S56D 11 10 
5 S56E -2 -7 
6 K58D 5 n.p. 
7 K58E u 1 
8 K65D n.p. n.p. 
9 K65E 7 1 
10 E81K 9 6 
11 
Amino Acid 
Conservation 
V26F u 3 
12 K40N 4 3 
13 G41D 7 -6 
14 S54N n.p. n.p. 
15 A68P 3 4 
16 D116K 2 0 
 
Table 1. The ΔT (°C) of the new designed thermostable mutants compared to SCP-2L V83C and 
A100C ( n.p, no data due to lack of protein; u, unreliable Tm,app obtained) This fast scan 
method is used serve the purpose of indicating how the thermostability is affected by the new 
amino acid introduced the data is approximate and the ΔT (°C)  error is within  3 °C. 
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3.6 Design and synthesis of Double mutants 
 
Within the literature, it is reported that combining mutations that increase thermostability 
can give an enhanced effect.32 Therefore, the three best results were taken, S56D, E81K, N31D 
and six double mutants were successfully produced according to the same protocol as the 
single mutants.  
 
3.7 CD spectroscopy analysis of double mutants 
 
Using CD spectroscopy, the melting temperature (Tm,app) of V83C and A100C and the 
thermostable double mutants were measured using data points taken at every degree point 
at 222 nm (Table 2). This CD method provides a more accurate value than the fast scan 
approach used in the previous screen as a larger number of data points are utilised. A Thermal 
denaturation curve is produced and from this the Tm app can be extrapolated.  
 
Variant Tm,app (°C) DT °C 
V83C template 48  
A100C template 42  
A100C N31D S56D 58 +16 
A100C N31D E81K 55 +13 
A100C E81K S56D 41 -1 
V83C N31D S56D 60 +12 
V83C N31D E81K 62 +14 
V83C E81K S56D 64 +16 
Table 2. Apparent melting temparatures (Tm,app) of SCP-2L  mutants determined using CD, 
measuring the absorbance at 222 nm at 1°C steps.  The data is accurate to the nearest degree. 
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The new thermostable mutants showed impressive improvements in thermostability, 
increasing the Tm,app by 12-16 °C in all but one case. However, variant A100C/E81K/S56D, 
showed a negative effect of combining E81K and S56D mutations and the Tm,app decreased 
by 1 °C. This protein was obtained in very low yields (2mg/L) so the protein was not used 
further in this work.  
 
  
                Fig. 5 – Thermal Denaturation Curve of Double SCP-2L Mutants  
 
The rational design method proved successful and an increase of protein thermostability was 
obtained. Therefore, the next step was to test the hypothesis to see if this would result in a 
more stable catalyst. Hydroformylation was chosen as a benchmark reaction because it is the 
most studied reaction using SCP-2L as a protein scaffold for ArMs. Previous results reported 
by the Kamer group showed that SCP-2L A100C and V83C rhodium proteins showed 
significant hydroformylation activity of up to 400 and 100 TONs respectively over 48 h. These 
activities were surprisingly high considering that the reactions were carried out at 35 °C, 
which is considerably lower than typically used in industrial conditions. With a more stable 
protein scaffold, the activity could increase further as less catalyst degradation will occur over 
time allowing for higher temperatures. 
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3.8 Hydroformylation catalysis using double mutants 
 
3.8.1 Protein modification 
 
The SCP-2L mutants were successfully modified with an aldehyde phosphine (P) through a 
two-step cysteine modification (Scheme 2). The rhodium proteins (SCP-2L A100C/V83C-1-P-
Rh) were obtained by the addition of Rh(acac)(CO)2 to the phosphine modified proteins. In 
order to ensure all rhodium is bound an excess (2 eq.) of protein was used. If ‘free Rh’ is 
present it will have hydroformylation activity leading to low selectivity for the linear aldehyde 
(ca. 55%) and high TON’s (TONs >500) (Table 3 Reaction Entry 15). 
 
Previous work in the Kamer group investigated the effect of the structure of the phosphine 
cofactor used. The activity was found to increase as the phosphine moved from the ortho to 
meta, and ortho to para position by 30-fold and 70-fold respectively for SCP-2L V83C. 
Therefore, in this work only the phosphine cofactor in the para position was utilized.10 
 
 
 
 
Scheme 2 – Synthesis of the artificial metalloproteins 
 
 
protein-SH
(free cysteine)
N
O
N
H
NH2
O
O N
O
N
H
NH2
O
OSprotein
N
O
N
H
N
O
OSprotein
PPh2
O
PPh2
H
MES buffer
pH 6.0
MES buffer
pH 6.0
Rh(acac)(CO)2
N
O
N
H
N
O
OSprotein
PPh2
[Rh]
1
P
 59 
3.8.2 Hydroformylation of 1-octene catalyzed by rhodium-hydroformylase 
The hydroformylation (Scheme 1) activities of each of the five new double mutants were 
investigated using 1-octene as the substrate and compared to the original SCP-2L A100C and 
V83C. The reactions were carried out under the same conditions as previously published10, 
except for the reaction time, which was shortened to 16 h (Table 3). 
 
Reaction 
Entry 
Mutant Temp ºC 
Selectivity 
Linear Aldehyde 
(%) (average) 
TON (average) 
1 
V83C 
35 79.2 (0.15) 42.8 (0.34) 
2 45 77.8 (0.09) 11.5 (1.27) 
3 
V83C E81K S56D 
35 78.3 (0.08) 92.1 (0.97) 
4 45 79.5 (0.12) 190.3 (1.11) 
5 
V83C N31D E81K 
35 80.1 (0.10) 103.7 (0.89) 
6 45 78.4 (0.32) 201.4 (0.93) 
7 
V83C N31D S56D 
35 74.5 (0.07) 98.7 (1.02) 
8 45 76.8 (0.87) 180.4 (1.23) 
9 
A100C 
35 79.9 (0.06) 210.8 (0.65) 
10 45 75.4 (0.15) 98.9 (2.90) 
11 
A100C E81K S56D 
35 79.3 (0.65) 201.5 (1.32) 
12 45 78.2 (1.10) 321.6 (3.14) 
13 
A100C N31D E81K 
35 71.9 (0.21) 213.4 (0.44) 
14 45 73.4 (0.54) 345.7 (2.12) 
15[*] Rh(acac)(CO)2 35 55.3 (0.67) 529.7 (53.30) 
 
Table 3. Hydroformylation of 1-octene catalyzed by rhodium-hydroformylase Conditions: 80 
bar syngas (1:1), stirring 625 rpm, 16 h in degassed MES buffer, 0.5 mL of catalyst solution 
and 0.5 mL of alkene containing 9% (v/v) n-heptane and 1% (v/v) diphenyl ether. Results are 
the average of three repeated reactions, standard deviation between brackets. Yields 
determined by GC .[*} Reaction entry 15 is a  free  Rh(acac)(CO)2  published control: 41.25 h, 
total volume: 0.4 mL 1-octene, no water, 150 nmol Rh.10  
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All three of the new thermostable SCP-2L V83C mutants (V83C E81K S56D/ V83C N31D E81K/ 
V83C N31D S56D) showed an improvement in TONs compared to SCP-2L V83C at 35 °C. SCP-
2L V83C E81K S56D gave a TON of 92.1 which is double that seen of SCP-2L V83C under the 
same conditions (Table 3, entry 3 vs. 1). This suggests a possibility that when using V83C as a 
rhodium protein catalyst, there is significant protein degradation and increasing the stability 
of the protein enables the catalyst to be active throughout the 16-h reaction. To test this 
further, the reaction temperature was increased to 45 °C, the hypothesis being that rates 
would increase at higher temperatures if the protein continues to be stable. For SCP-2L V83C 
(Table 3 entry 2) a significantly reduced TON was observed, most likely due to rapid 
denaturation of the protein. However, the new thermostable rhodium proteins remained 
active at this higher temperature and produced high TONs of up to 200 (Table 3 entry 6). 
 
The two new thermostable A100C mutants (A100C N31D E81K/ A100C N31D S56D) showed 
no improvement but consistent results with A100C. However, when the reaction temperature 
was increased to 45 °C these rhodium proteins were stable unlike the parent A100C and 
showed an increase in TONs up to 345 (Table 3 entry 14). This increase in TON is what would 
be expected by increasing the reaction temperature by 10 °C and indicates that the new 
designed A100C mutant is stable and can retain its structure at 45 °C. 
 
The selectivity of the reaction varied between 75 and 80% for the linear product (nonanal), 
matching typical selectivities for double phosphine ligated rhodium catalyzed 
hydroformylation.33 The rhodium used in this work is mono-phosphine ligated rhodium which 
normally would give lower selectivities.34 This suggests that the protein scaffold counter 
balances the lack of phosphine ligands.  
 
To test the stability of the artificial metalloenzymes further the reaction time was increased 
to 48 h to see if the TON could be increased (Table 4). The new thermostable V83C mutants 
showed an increase of TON from the original V83C of 74 up to 220 (Table 4 entry 1 and 3 
respectively) and when the temperature was pushed to 45 °C the TON was pushed up to 406 
(Table 4, entry 8). This suggests that the new thermostable mutant is capable of retaining its 
structure at this higher temperature and can maintain this for at least 48 h. The stabilized 
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A100C thermostable mutants showed a less impressive stability at 45 °C for 48 h, suggesting 
that after 16 hr the protein scaffold begins to denature, which is corroborated by a large 
buildup of white precipitate. 
 
 
 
Table 4. Hydroformylation of 1-octene catalyzed by rhodium-hydroformylase. The conditions 
used were 80 bar syngas (1:1), stirring 625 rpm, 48 h in degassed MES buffer, 0.5 mL of 
catalyst solution and 0.5 mL of alkene containing 9% (v/v) n-heptane and 1% (v/v) diphenyl 
ether. In all examples, the reaction substrate is 1-octene (Scheme 1), the average taken in all 
examples is of three repeated reactions, standard deviation between brackets. Yields 
calculated by GC. 
 
 
Reaction 
Entry 
Mutant Temp ºC 
Selectivity 
Linear Aldehyde 
(%) (average) 
TON (average) 
1 
V83C 
35 78.3 (1.21) 75.7 (1.32) 
2 45 75.8 (1.03) 27.3 (0.98) 
3 
V83C E81K S56D 
35 79.8 (0.67) 220.8 (1.84) 
4 45 79.3 (0.93) 385.2 (3.87) 
5 
V83C N31D E81K 
35 79.6 (1.10) 198.9 (1.98) 
6 45 78.4 (0.65) 404.3 (4.19) 
7 
V83C N31D S56D 
35 77.4 (1.9) 203.7 (2.81) 
8 45 79.6 (0.83) 401.8 (4.35) 
9 
A100C 
35 78.8 (0.76) 400.9 (3.87) 
10 45 70.0 (1.59) 170.9 (2.69) 
11 
A100C E81K S56D 
35 77.3 (1.24) 406.1 (5.21) 
12 45 72.5 (0.87) 414.8 (3.86) 
13 
A100C N31D E81K 
35 71.9 (1.31) 403.4 (3.54) 
14 45 72.9 (1.26) 325.5 (2.85) 
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3.9 Conclusions and Further Work  
 
In conclusion, it has been shown that the stability of the protein scaffold within an ArM is very 
important to the catalytic activity. By improving the thermostability of the SCP-2L V83C 
scaffold by up to 16 °C, the reactivity of the ArM was increased at higher temperatures. With 
the stabilized hybrid enzymes, the TON improved over 5-fold reaching values of up to over 
400 (Table 4). Thus, rational mutant design for optimization of the ArM stability yielded a 
biocatalyst that enables an increased range of reaction conditions and higher activities. The 
rhodium phosphine modified ArMs have been shown to be effective linear selective catalysts 
in hydroformylation reactions and showed a race enhancement of at least 103 compared to 
traditional Rh/TPPTS system in the biphasic hydroformylation of 1-octene and 1-decene.10 
 
Moving forwards this approach has the potential to be used for a range of reactions, which 
traditionally use phosphines as ligands and convert these into biocatalytic processes. 
Combining mutation points, which both showed an increased stability, was shown to have an 
almost additive effect to the protein scaffold. In order to continue to increase the proteins 
stability, the mutant library should be expanded, and a larger number of mutation points 
combined. By designing an assay that could be used to screen for ArM activity using a large 
mutant library would be more convenient. This could even be expanded to utilizing 
bioengineering tools such as directed evolution.  
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3.10 Experimental 
 
3.10.1 General Remarks 
Mass Spec measurements were taken on a Waters Alliance HT 2795 equipped with a 
Micromass LCT-TOF mass spectrometer, using positive electrospray ionisation. UV-visible 
measurements were recorded on a Molecular Devices M2 Spectra Max spectrophotometer. 
 
3.10.2 Protein Crystal Structures – Protein Crystallization carried out by Lorenz Obrecht and 
Refinement Carried out by Megan Doble & Emma Branigan 
A100C data set from Jan 2011 at 2.48 Angstrom resolution:  
A100C was concentrated to ~2.1 mg/ml in 20 mM Pipes pH 7.5, 1 mM EDTA, 1 mM sodium 
azide, 150 mM NaCl, 0.15 mM Triton X100.   
V83C data set from August 2012 at 2.09 Angstrom resolution: 
V83C was concentrated to ~2.5 mg/ml in 20 mM Pipes pH 7.5, 1 mM EDTA, 1 mM sodium 
azide, 150 mM NaCl, 0.15 mM Triton X100. Crystals were grown at at 4 °C by hanging drop 
vapour diffusion in 2.2 M ammonium sulfate, 0.2 M NaCl, 0.1 M citric acid pH 5.4 and cryo-
protected with 25 % sucrose.  
CCP4 suite and COOT were used for refinement. 
Data Collection A100C V83C 
Space group                                                                                                           P212121 P212121 
Cell dimensions     
    a, b, c (Å)    35.38, 50.75, 63.10 63.74, 35.69, 48.85 
    α, β, γ  (°)     90.00, 90.00, 90.00 90.00, 90.00, 90.00 
Resolution (Å)   50.00 – 2.48 (2.52 – 2.48)a 28.82 – 2.09 (2.15-2.09) 
Rsym or Rmerge    7.0  (51.5) 5.9 (18.1) 
I / sigma    29.4 (2.9) 23.4 (10.7) 
Completeness (%)   85.8 (100) 99.1 (96.5) 
Redundancy    6.4 (4.5) 6.8 (5.9) 
Refinement 
Resolution (Å)   29.04 – 2.48 28.82 – 2.09 
No. reflections                                                                       3469 6538
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Rwork / Rfree   20.7 / 28.3 21.2 / 25.6 
No. atoms   929 979 
B factors  53 20 
r.m.s. deviations   
Bond lengths (Å)  0.017 0.011 
 Bond angles (°)  1.6 2.1 
aValues in parentheses are for highest-resolution shell. 
 
3.10.3. Site Directed Mutagenesis 
Mutations were introduced using the Quik-Change Site-Directed Mutagenesis Kit 
(Stratagene) with pEHISTEV::dΔhΔSCP-2L as the template. The primers used for the 
mutagenesis are shown below. The constructs were verified by sequencing by GATC. 
Primers for SCP-2L A100C & V83C Templates 
Mutation 
acquired 
Sequence (5' - 3') 
I44E CCAAAGGCGGAAATGAAGGGGCTAAGTGGAC 
GTCCACTTAGCCCCTTCATTTCCGCCTTTGG 
I44D CCAAAGGCGGAAATGATGGGGCTAAGTGGAC 
GTCCACTTAGCCCCATCATTTCCGCCTTTGG 
S56E GACCTGAAAAGTGGTGAGGGAAAAGTGTACCA 
TGGTACACTTTTCCCTCACCACTTTTCAGGTC 
S56D GACCTGAAAAGTGGTGACGGAAAAGTGTACCA 
TGGTACACTTTTCCGTCACCACTTTTCAGGTC 
K58E CTGAAAAGTGGTTCTGGAGAGGTGTACCAAGGCCCTGC 
GCAGGGCCTTGGTACACCTCTCCAGAACCACTTTTCAG 
K58D CTGAAAAGTGGTTCTGGAGACGTGTACCAAGGCCCTGC 
GCAGGGCCTTGGTACACGTCTCCAGAACCACTTTTCAG 
K65E GTACCAAGGCCCTGCAGAGGGTGCTGCTGATACAAC 
GTTGTATCAGCAGCACCCTCTGCAGGGCCTTGGTAC 
K65D GTACCAAGGCCCTGCAGACGGTGCTGCTGATACAAC 
GTTGTATCAGCAGCACCGTCTGCAGGGCCTTGGTAC 
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N31D CTGAGGTGGTGAAGAAAGTAGACGCTGTATTTGAGTGG 
CCACTCAAATACAGCGTCTACTTTCTTCACCACCTCAG 
V26F GGATATTGGGCCTGAGTTCGTGAAGAAAGTAAA 
TTACTTTCTTCACGAACTCAGGCCCAATATCC 
G41D GGCATATAACCAAAGACGGAAATATTGGGGC 
GCCCCAATATTTCCGTCTTTGGTTATATGCC 
S54N GTGGACTATTGACCTGAAAAATGGTTCTGGAAAAGTGTAC 
GTACACTTTTCCAGAACCATTTTTCAGGTCAATAGTCCAC 
D116K CTCAGAGCTTGGCATATTTTTTAAGAATCATCTGAAGTTTCTGGC 
GCCAGAAACTTCAGATGATTCTTAAAAAATATGCCAAGCTCTGAG 
K40N GTGGCATATAACCAACGGCGGAAATATTGGG 
CCCAATATTTCCGCCGTTGGTTATATGCCAC 
A68P GCCCTGCAAAAGGTGCTCCTGATACAACAATCATAC 
GTATGATTGTTGTATCAGGAGCACCTTTTGCAGGGC 
Mutation 
acquired 
Protein Scaffold Sequence (5' - 3') 
E81K A100C CAGATGAAGATTTCATGAAGGTGGTCCTGGGCAAG 
CTTGCCCAGGACCACCTTCATGAAATCTTCATCTG 
V83C GATGAAGATTTCATGAAGGTGTGCCTGGGC 
GCCCAGACGCACCTTCATGAAATCTTCATC 
 
The constructs were prepared as follows: SCP-2L A100C and V83C were used as the template 
DNA where appropriate. Site directed mutagenesis was carried out. The reaction was set up 
as follows: Primer fw: 0.01 μM (0.25 μM, 0.5 μL), primer rv: 0.01 μM (0.25 μM, 0.5 μL), SCP-
2L template DNA (0.5 μL), PfuUltra Master Mix (10 μL), Sterile MilliQ Water 
After mixing, the PCR tubes were spun briefly (4 sec, table top centrifuge, RT). The tubes were 
transferred to a PCR machine and the following PCR cycle ran. 
1.  Initial Denaturation 95 °C, 5 min 
2. Denaturation 30 sec 95 °C 
3. Annealing 1min 55 °C 
4. Extension 1min/1kp 72 °C 
5. Repeat Steps 2-4 for 16 cycles 
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6. Final extension 20 min 72 °C 
Digestion of the wild type template strand was then performed as follows: PCR product (8.5 
μL), 10x Fast digest buffer (1 μL) and Dpn1 (0.5 μL) were incubated at 37 °C for 10 min, 
followed by inactivation at 72 °C for 5 min. The digested products were transformed into 
commercial DH5α cells and grown on kanamycin (50 μg/mL) agar plates at 37 °C overnight. 
 
3.10.4 Protein Expression and Purification 
 
General Expression and Purification Protocol:  
Protein expression and purification was performed as described in literature6 
  
SCP-2L A100C was prepared by transforming the pEHISTEV::dΔhΔSCP-2L A100C plasmid into 
competent E. coli Rosetta(DE3) cells. A single transformed colony was inoculated into 10 mL 
PB medium (Production Broth medium; containing 20 g/L tryptone, 10 g/L yeast extract, 5 g/L 
dextrose, 5 g/L NaCl, 8.7 g/L K2HPO4, pH 7.0) with 50 μg/mL kanamycin and 34 μg/mL 
chloramphenicol (in ethanol). This was used to inoculate 100 mL PB media (50 μg/mL 
kanamycin and 34 μg/mL chloramphenicol) and agitated at 37 °C, 200 rpm overnight (16-18 
h).  This starter culture (10 mL) was used to inoculate 0.5 litre of PB medium (2 litres in total). 
The cells were allowed to grow at 37 °C to an OD600 of 0.6 (about 2 h) after which the 
temperature was lowered to 16 °C. Isopropyl-1-thio-β-D-galactopyranoside (IPTG) was added 
after one hour to a final concentration of 0.2 mM from a 0.2 M stock solution to initiate the 
expression of the recombinant protein. The culture was left overnight at 16 °C (16-18 h). The 
cells were harvested by centrifugation (20 min, 7500 g), washed with 250 mL of buffer 
solution (16 mM kPi (potassium phosphate) 120 mM NaCl, pH 7.4) and centrifuged again (20 
min 7500 g). The pellet from the 2 litre cell culture was resuspended at 4 °C in 100 ml of buffer 
solution (50 mM Tris·HCl, 20 mM imidazole, 150 mM NaCl, 0.5 mM benzamidine, pH 8) and 
frozen at -80 °C.  
 
After defrosting, 20 mg of lysozyme, 1 mg of DNase and 1 mL of 1 M of MgCl2 was added to 
the suspension. The suspension was left for 1 hour at 4 °C and was sonicated in portions of 
10 mL (Hielscher UP200S ultrasonic processor, 0.5 s pulses 90% power) with 0.5 second pulses 
for 1 minute. The cell-extract, obtained after centrifugation (50 min, 30000 g) was filtered 
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(0.22 μm PES Millex Filter unit) and applied to a nickel column (5 mL HisTrap FF) equilibrated 
with 30 mM Tris·HCl, 20 mM imidazole, 150 mM NaCl, pH 8 (wash buffer) at flow rates up to 
5 mL/min. The column was washed with 5 column volumes of wash buffer, 5 column volumes 
of high salt buffer (wash buffer containing 1 M NaCl) and another 5 column volumes of wash 
buffer. The protein was obtained by eluting with 6 column volumes elution buffer (wash 
buffer containing 330 mM imidazole) into an equal volume of wash buffer to prevent 
precipitation of the protein and the resulting solution was dialysed against 5 litre buffer 
solution (30 mM Tris·HCl, 10 mM imidazole, 150 mM NaCl, pH 8 at 4°C). If precipitate had 
formed the resulting mixture was centrifuged (30000 g, 50 min). 0.014 equivalents of TEV-
protease and final concentrations of 1 mM DTT and 0.5 mM EDTA were added to the resulting 
His-tagged SCP-2L A100C solution. This mixture was left overnight at room temperature. 
 
If precipitate had formed the mixture was again centrifuged (50 min, 30000 g) and the pellet 
was discarded. The supernatant was then filtered (0.22 μm PES Millex Filter unit) and used 
for nickel affinity chromatography on a nickel column (5 mL HisTrap FF) equilibrated with 
wash buffer. The flow-through containing pure SCP-2L A100C was collected, concentrated 
and the buffer was exchanged to the storage and coupling buffer (20 mM MES, 50 mM NaCl, 
pH 6) using a centrifugal concentrator. Three consecutive rounds of buffer exchange were 
performed to remove all the DTT. Buffer exchange by centrifugal concentrator was found to 
be more effective than dialysis.  Yields up to 75 mg L-1 culture, with a purity of more than 
>99% according to SDS-PAGE (Nupage™ 4-12% Bis-Tris gel), were obtained.  
 
When expressing and purifying protein on a small scale for CD analysis the method was 
adjusted onto a smaller scale using 500 ml culture for each protein. The only difference was 
that instead of using a HiTrap pre packed column, the protein supernatant was incubated with 
Ni-NTA resin for 1 hour and then eluted using a spin column. The Ni-NTA resin used had a 
binding affinity of 50 mg/ml. Expression was successful for all mutants with an average yield 
of 20 mg L-1 culture. This slight decrease in yield is likely due to the accelerated purification 
protocol. 
 
 
 
 68 
SDS Gel Characterisation: 
SDS page gel (Nupage™ 4-12% Bis-Tris gel): 
 
 
 
 
 
 
 
 
 
 
 
 
L = SeeBlue Plus 2 Prestained Protein Standard ladder 
1. A100C                                9. A100C K58E 
2. V83C                                  10. A100C I44D 
3. A10C N31D                       11. A100C K58D 
4. A100C S56E                      12. A100C K65E 
5. A100C E81K                      13. A100C S56D 
6. A100C S54N                      14. A100C K40N 
7. A100C G41D                     15. A100C V26F 
8. A100C K65D 
 
3.10.5 CD Studies to determine thermostability 
 
Circular dichroism spectra were obtained using a Biologic MOS-500 spectrometer. A Xe lamp 
was used, and the near UV spectra taken from 190 – 260 nm using a 10 mm pathlength cell.  
The other parameters were as follows: 0.25 nm step, 0.5 s acq period, 3 repeats, ±MD 30 and 
slit size 2 nm. Thermal denaturation curves were obtained by plotting the CD values at 222 
nm of each spectrum against temperature. The thermal melt curves were fitted using the 
Boltzman sigmoidal fit function of Origin 6.0. 
1       2     3      4      5      6    7     8       9    10    11                        12  13   14         15 kDa 
 
98 
 
49 
 
 
28 
 
17 
 
14 
6 
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Using circular dichroism (CD) spectroscopy an approximate Tmapp was measured and 
compared SCP-2L A100C and V83C encoded by the original plasmid. The CD method used a 
fast scan approach only measuring 6 different temperature points; therefore, the Tm values 
are approximate and serve the purpose of indicating how the thermostability is affected by 
the new amino acid introduced (Figure 6). 
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Figure 6 - Using CD spectroscopy, the accurate melting temperature (Tm) of V83C and A100C 
and the thermostable double mutants were measured using data points taken at every degree 
point at 222 nm 
 
3.10.6 Protein Modification 
 
All reactions involving phosphines were performed under an argon atmosphere using 
degassed solvents and standard Schlenk techniques. Buffer solutions were degassed by 
bubbling argon through the solution. Protein solutions were degassed by washing and 
concentrating three times with degassed buffer using a filter unit set up as shown in Figure 5. 
Protein concentrations were determined by Bradford’s reagent.  
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Figure 5: Application of Amicon® Ultra-15 Centrifugal Filter Unit under inert atmosphere using 
a large custom made Schlenk flask.10 
 
Modification of the protein scaffold was carried out according to literature procedures. For 
the rhodium complex formation, the Rh:P ratio aimed for depended on application. For 
characterisation a 1:1 ratio was used. For catalysis an excess of phosphine, approximately 2 
equiv. per Rh was used to ensure that no ‘free Rh’ is present. Free Rh-catalysed 
hydroformylation is characterised by high TON’s and low linear to branched selectivities. 
Slight inconsistencies in protein concentration, through loss in handling or oxidation of the 
phosphine have the potential to lead to excess Rh over phosphine if a 1:1 ratio is used.  
Rh(acac)(CO)2 was used as the rhodium source,  and added as a freshly made solution in DMF.  
 
3.10.7 Mass Spectrometry of the modified proteins 
LC-MS(ES+) used for analysis of protein and modification reactions was carried out on a 
Waters Alliance HT 2795 equipped with a Micromass LCT-TOF mass spectrometer, using 
positive electrospray ionisation and applying a Waters MASSPREP® On-line Desalting 2.1x10 
mm cartridge using a gradient of 1% formic acid in H2O to 1% formic acid in acetonitrile. ESI-
MS results were analysed by MassLynx V. 4.0 and its MaxEnt algorithm. The samples for 
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phosphine modified proteins were prepared immediately before injection to reduce the 
oxidation of the sample.  
 
 
 
 
 
 
 
 
 
 
Deconvoluted mass-spectrum of modified proteins Blue A100C 13404.3Da (Calc.13404.6 Da): 
Red A100C-1 13588.0 Da (Calc. 13587.9 Da): Green A100C-1-P 13860.2 (Calc. 13860.2 Da): 
Purple A100C-1-P-Rh(CO) 1396462 Da (Calc. 13964.1 Da) obtained by LC-MS (ESI+) 
 
 
 
 
 
 
 
 
 
 
Deconvoluted mass-spectrum of modified proteins Blue A100C N31D E81K 13404.7 Da 
(Calc.13404.7 Da): Red A100C N31D E81K-1 13587.9 Da (Calc. 13587.9 Da): Green A100C 
N31D E81K-1-P 13860.1 (Calc. 13860.2 Da): Purple A100C N31D E81K-1-P-Rh(CO) 13964.3 Da 
(Calc. 13964.1 Da) obtained by LC-MS (ESI+) 
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Deconvoluted mass-spectrum of modified proteins Blue A100C E81K S56D 13431.5 Da 
(Calc.13431.7 Da): Red A100C E81K S56D -1 13615.0 Da (Calc. 13614.9 Da): Green A100C E81K 
S56D-1-P 13887.6 (Calc. 13887.2 Da): Purple A100C E81K S56D-1-P-Rh(CO) 13991.0 Da (Calc. 
13991.1 Da) obtained by LC-MS (ESI+) 
 
 
 
 
 
 
 
 
 
 
 
Deconvoluted mass-spectrum of modified proteins Blue V83C 13376.3 Da (Calc.13376.6 Da): 
Red V83C-1 13560.2 Da (Calc. 13559.8 Da): Green V83C-1-P 13832.4 (Calc. 13832.1 Da): 
Purple V83C-1-P-Rh(CO) 13936.1 Da (Calc. 1336.01 Da) obtained by LC-MS (ESI+) 
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3.10.8 Hydroformylation  
General Hydroformylation Procedure: 
 
Hydroformylation reactions were carried out in stainless steel autoclaves (up to two 
simultaneously) containing up to eight glass reaction vials (volume of approximately 5 mL) 
each. The reaction vials were equipped with stirring bars as well as a septum cap pierced with 
a needle in order to allow contact with the reaction gases. The prepared vials were placed in 
an autoclave which was flushed three times with >20 bar argon before adding the chemicals. 
The vials were charged under an argon blanket. The aqueous Rh-enzyme solution was added 
to each vial (0.5 mL, 20 mM MES, 50 mM NaCl, pH = 6). A protein-P : Rh ratio of 2 : 1 was 
aimed for and an aliquot of this solution was saved for ICP-MS analysis to obtain the actual 
Rh concentration. An organic solution consisting of 1-alkene, 9% (v/v) heptane and 1% (v/v) 
diphenyl ether as internal standards, freshly filtered over activated alumina (dried under 
vacuum at 150 °C for at least 5 hours) to remove peroxides, was added (0.5 mL). The autoclave 
was then flushed 3 times with about 20 bar syngas (H2 : CO 1 : 1) and subsequently charged 
to the desired pressure (80 bar). The autoclave was then placed into an oil bath that was 
preheated to the desired temperature (35 °C) and pre-set to the desired stirring speed (625 
rpm). After the reaction time (48 h) the reaction was stopped by putting the autoclave on ice 
for at least 15 mins and slowly releasing the pressure. The organic phase was analysed by GC, 
and ICP-MS for metal leaching. All experiments were run in triplicate.  
 
Gas Chromatography: 
An Agilent 7820A GC system with autosampler was used for GC analysis. This GC was installed 
with an Agilent HP-5 column 30m x 0.32 mm x 0.25 μm. Conditions: injector temperature 250 
°C; FID detector temperature 300 °C; 6.5 mL/min constant flow; 75:1 split ratio; 1 μL injection; 
oven method: 25 °C isotherm for 6 min, 10 °C/min to 60 °C, 20 °C/min to 300 °C. Retention 
times: heptane 2.05 min, 1-octene 4.45 min, 2-methyloctanal 11.34 min, n-nonanal 11.83 
min, diphenyl ether 14.19 min. Due to the large excess of 1-alkene, resulting in the broad 
tailing alkene peak, it was not possible to detect small amounts of isomerization products.  
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This hydroformylation work is an extension of previously published work by Dr Amanda Jarvis, 
so all controls and hydroformylation using Rh/TPPTS carried out by her can be seen in 
literature.10 
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Artificial Metalloenzymes as Catalysts for Oxidative Lignin Degradation 
Chapter 4 – Artificial Metalloenzymes as oxidation catalysts for lignin degradation1 
4.1 Introduction to lignin 
The rapid depletion of fossil fuels as a resource for energy and chemicals production 
necessitates a future change to an increase in the use of biomass, ideally through the 
development of biorefineries that provide a wide range of products. The most abundant 
renewable resource in this context is lignocellulosic biomass, which is much more plentiful 
than alternative feedstocks such as sugars, starch, oils and fats.2 Another advantage is that it 
does not compete with food sources for land.  Lignocellulose, consisting of 40-50% cellulose, 
16-33% hemicellulose and 15-30% lignin,3 is therefore viewed as an abundant future source 
of fuel and chemicals.4,5 Whilst the technologies for the exploitation of cellulose and 
hemicellulose are well established, lignin is currently underutilised with only one commercial 
process in operation – the preparation of vanillin.6 The major hurdle for the complete 
exploitation of lignocellulosic biomass, including lignin, is the efficient depolymerisation of 
lignin.7,8 In the biorefinery, cellulose and hemicellulose can provide sugars, alcohols and 
alkane based products, whilst lignin has the potential to be the major natural source of 
aromatic compounds to replace oil. Therefore, novel methods to overcome the 
depolymerisation limitation are required.  
4.1.1 Structure and Functionality of Lignin 
Lignin is a naturally occurring aromatic non-ordered polymer (Figure 1), which fills the spaces 
in the cell wall between cellulose and hemicellulose components. Plants obtain their 
structural integrity by utilising lignin as a resin. The biological design of lignin protects plants 
from attack by microorganisms, and this helps to prevent hydrolysis of cellulose. This complex 
three-dimensional polymer is covalently linked to hemicellulose and gives mechanical 
strength to the cell wall. It is largely hydrophobic in comparison to cellulose, which is 
hydrophilic, so is intertwined by hemicellulose, which contains both hydrophobic and 
hydrophilic sections. The distribution of this polymer within the cell wall is not uniform, and 
the amount of lignin present within a plant also varies dependent on species. 
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The polymer we refer to as lignin is regarded as the structure after extraction, and protolignin 
is lignin when still associated with cells. The exact structure of protolignin is still unknown as 
is its biosynthesis, however it is thought to involve the polymerization of the monomeric units; 
p-coumaryl, coniferyl and sinapyl alcohols (Figure 1).9 Softwood and hardwood lignin have 
different compositions based upon the abundance of each of the monolignols. The coniferyl 
alcohols make up 90% of softwood lignin, whereas comparatively the amount of coniferyl 
alcohols is similar to the sinapyl alcohols in hardwood lignin.2  This polymerization is thought 
to occur through an oxidative coupling reaction via radicals, in nature these would be 
generated by a peroxidase using H2O2 as an oxidant.10 
 
Figure 1 – The three monolignols, the building blocks of lignin 
Structural studies are complex and limited because different extraction techniques to isolate 
lignin are known to alter protolignin in different manners. Additionally, the determination of 
the structure of protolignin itself has so far not been successful. What is known about this 
structure is, it is comprised of a number of varying linkages that connect together different 
structural units (Figure 2), these include β-O-4, β-5, β-β, 5-5, 4-O-5 and β-1 couplings.11 The 
β-O-4, arylglycerol-β-aryl ether, is the most abundant linkage found in lignin with 
approximately 50% in softwood and 80% in hardwood. This is thought to be because the 
phenolic and β-hydrogen are shared between all three monolignols, so will be involved in a 
large number of the linkages. 
The ability to structurally characterise lignin is a key area of development. This will become 
crucial in order to benefit from lignin’s natural aromatic structure and produce aromatic 
chemicals. 
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Figure 2 – Representation of lignin type structure highlighting the linkages and monolignols 
4.1.2 Naturally occurring lignin degradation 
Lignin is predominately resistant to most microorganisms’ attack, and any degradation that is 
seen is very slow. The white rot fungus Phanerochaete chrysosporium, is a naturally occurring 
organism that can cleave lignin, and is the only known organism that can completely degrade 
lignin to carbon dioxide and water.12 White rot fungi are named as such due to the specific 
oxidative bleaching of wood. These fungal organisms utilise four main enzymatic groups for 
the degradation of lignin, three of these are peroxidases and one is a laccase.  
The most extensively studied lignin degrading microorganisms are Phellinus sp., Daedalea sp., 
Trametes versicolor and Pycnoporus coccineus as these species possess high ligninolytic 
activity. In general, the lignin breakdown for fungal species was approx. 20-30% over a 60-day 
period. 13 This is a very slow rate to apply the biocatalysts on an industrial scale, so the use of 
these species is unachievable. However, the mechanism of action of white rot fungus can be 
used as inspiration for a solution. 
While a large amount of the present research focuses on fungal lignin degradation, various 
bacterial species have also been shown to metabolize lignin.14, 15, 16, 17 However, bacterial 
systems are often less powerful as oxidation catalysts in comparison to fungal systems.18 At 
present research is being carried out looking at microbial systems that can be used to 
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breakdown lignin and could possibly provide molecular information on lignin 
depolymerisation. Developments in physiological and structural studies of these organisms 
could lead to identify chemical transformations on lignin.18 
4.1.3 Transition Metal Catalysts for Lignin Oxidation 
At present there are many transition metal catalyzed oxidation methods known for lignin and 
lignin model compound valorization.2,19,20  
Currently there is research utilising Methyltrioxorhenium (MTO) as a catalyst for lignin 
oxidation. MTO is an organometallic compound that contains a Rhenium atom with a 
tetrahedral geometry with one methyl and three oxo ligands. MTO can activate oxidizing 
species such as hydrogen peroxide,21 and MTO-activated hydrogen peroxide is able to oxidize 
challenging substrates. This MTO-activated peroxide system was shown to have the ability for 
oxidative cleavage of lignin and a large array of lignin model compounds. MTO was able to 
oxidize both phenolic and non-phenolic lignin model compounds through side chain 
oxidations and ring cleavage reactions.22 Work was also carried out on an MTO system to 
increase the lifetime by using a polymeric support. This method used polystyrene or poly(4-
vinylpyridine) beads showing slightly improved results23, however yields and selectivity’s 
were still rather low. In 2014 the group of Herrmann continued this work further looking at 
methyldioxorhenium (MDO). The MDO is generated in situ by reduction of MTO and showed 
to remain stable with no loss of activity over five cycles. The methyldioxorhenium catalysts 
were capable of C-O bond cleavage on a range of lignin model compounds.24 This stability is 
impressive and shows great potential, but research is needed to see if it will hold the same 
reactivity when used on lignin biomass. 
Methodology for the conversion of lignin β-O-4 linkage models is also being developed using 
Cu-catalysed aerobic amide bond formation (Scheme 1). This approach utilizes selective 
oxidation of the secondary alcohol of the β-O-4 link and then amide bond formation using a 
copper catalyst.25  Further investigation is required to see whether this system can be applied 
to natural lignin. 
 
 
 83 
 
Scheme 1- One-pot conversion of lignin β-O-4 models through copper catalyzed aerobic amide 
bond formation25 
Another catalyst system being explored for  use in lignin oxidation are salen complexes. These 
complexes are composed of transition metals and are often used with hydrogen peroxide to 
oxidize a wide variety of substrates.26 Salen ligands are Schiff bases, synthesized through the 
condensation of a salicylaldehyde with an amine. The oxidative mechanism of salen 
complexes was determined through EPR studies. This proceeds via initial formation of a 
phenoxy radical, which reacts with molecular oxygen to form oxidized lignin model 
compounds.27 [Co(salen)] showed a high conversion in a variety of lignin model compounds, 
although the substrates used are predominately very simple models. An example using salen 
= [N,N1-bis(salicylidene)ethane-1,2-diaminato] and a slightly more realistic β-O-4 model 
compound was also reported.33 Investigation using EPR showed that two phenoxy cobalt 
radicals are utilized in the mechanism of this oxidation reaction.33 The Co(salen) compounds 
are often cheaper than alternatives such as biomimetic metalloporphyrin complexes, because 
they are much simpler to synthesize and often more stable. Modifications of the salen ligand 
can be used to alter properties of the catalyst for example, such as the addition of sulfonato 
groups to the salen ligand to increase the solubility.28 
Catalytic aerobic oxidation is of great interest because the only side product would be water, 
and could be a cheap alternative to lignin oxidation. The use of vanadium catalysts in aerobic 
conditions has been studied.34 Interestingly, depending on the vanadium catalyst (Fig 3), the 
oxidation proceeded either via C-C cleavage or C-O cleavage. Toste’s catalyst (V1) breaks the 
C-O bond via cleavage of the benzylic C-H bond, whereas the quinolinate complex (V2) breaks 
the C-C bond. These vanadium complexes showed promising reactivity in oxidation of lignin 
model compounds, but it is thought that the mechanistic complexity and the number of steps 
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make them difficult to optimize. Recent work also showed that the vanadium catalysts could 
be applied to lignin samples and shows β-O-4 cleavage via nonoxidative depolymerisation.29 
 
 
 
 
 
Fig 3-Vanadium catalysts for the oxidation of lignin models  
Alongside research into organocatalysts for lignin oxidation, the group of Stahl also looked at 
metal catalysts for lignin oxidation.30  Chemo selectivity was seen in a few instances for 
oxidation of the secondary benzylic alcohol, but oxidation of the primary aliphatic alcohol was 
only observed alongside the secondary alcohol. Often the initial oxidation product of the 
primary aliphatic alcohol is also not seen because the reaction is followed by retro-aldol bond 
cleavage. 31,35 An increase in conversion was found upon the addition of oxidants and 
additives such as TEMPO [(2,2,6,6-Tetramethylpiperidin-1-yl)oxy]. The transition metal 
catalysis done in this work was complicated by the incorrect mass balance.  This could be 
interpreted in two manners, either an additional aqueous work up was needed, resulting in 
product loss. Alternatively the discrepancy in mass balance could be due to incomplete 
recovery of all products, which could be especially relevant with a low molecular weight 
product. Interestingly, AcNH-TEMPO/ HNO3/ HCl metal-free catalytic conditions were applied 
to Aspen lignin (hardwood) and it was determined that the β-O-4 linkages within lignin follow 
similar selectivity to that of the model compounds.35 
A lot of current research is about selectivity in oxidation of lignin model compounds, 
predominately within oxidation of primary or secondary alcohols. This is important because 
oxidation of both would lead to a mixture of products that could require difficult separation. 
However, it is important to be able to achieve both oxidations, because chemoselective 
oxidation of either alcohol could provide a scaffold for the production of aromatic chemicals 
from lignin. 
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It is possible that the different reagents and therefore different reaction mechanisms lead to 
this variety of products. Studies showed that the metal salt used to form the catalyst complex 
played a role in the selectivity and reactivity. For example, Cu(OTf)2 was too active and using 
CuBr2 instead while decreasing the activity, proved to be more selective for primary benzylic 
alcohol oxidation over the secondary position.32 
The exact mechanisms of many of these pathways often are still not known, as for example 
for the CuCl/bipy/TEMPO/KOtBu system used to catalyze the aerobic oxidation of primary 
alcohols.33 Contradicting studies suggested both coordination of the copper to TEMPO 
followed by a hydrogen transfer abstraction, and alternatively, an initial single electron 
transfer mechanism. 34 The CuCl/ TEMPO systems catalyze the oxidation of lignin model 
compounds under mild conditions via C-C bond cleavage. In comparison, a dipicolinate 
vanadium catalyst reacts to break the C-H bond generating different products.34 These 
different reactivity patterns for aerobic oxidation of lignin model compounds suggest that 
homogenous catalysts offer a possible option for the control of selectivity in lignin reactions. 
By controlling the catalyst, solvent and reaction conditions a wide array of possible aromatic 
products could be envisioned. 
Recent work of Wang and Rinaldi35 showed that not enough focus was put on the solvent 
effects within these catalytic reactions. They showed that Lewis basicity of the solvent 
controlled the reactions activity and selectivity. 
4.1.4 Biomimetic metalloporphyrins utilised in lignin oxidation 
Biomimetic approaches have been used to exploit structural features of heme groups within 
peroxidase enzymes to produce oxidative catalysts. One of the key differences between using 
a free metalloporphyrin in comparison to a heme-containing enzyme is that with enzymes 
they conceal the heme group within the protein scaffold, protecting it from bleaching by the 
oxidation agent. However, a free metalloporphyrin is less restricted so will have a wider 
substrate scope. 
Highly functionalized porphyrins with aryl substituents in the meso position of the ring are 
used as a catalytic system that is stable to oxidants. By varying the substituents, the change 
in electronic properties can control the solubility and redox potential of these catalytic 
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systems.36 Within the literature there is a large volume of work using biomimetic catalysts for 
oxidation of lignin and lignin model compounds, a review was written recently in 2013 by 
Zucca et al covering some of the recent work.37  
4.1.5 Artificial Metalloenzymes for lignin oxidation hypothesis  
A number of the homogenous catalytic methods outlined above have been successful at 
obtaining LigninOX a promising potential commercial intermediate.  However, there is still 
room for improvement in these methods (i.e. the use of greener oxidants, lower catalyst 
loading) and thus to obtain the greatest benefit from lignin as a possible source of fine 
chemicals, it is advantageous pursue many avenues. We were interested in pursuing an 
artificial metalloenzymes approach, as this may identify different selectivity’s or enable the 
improvement in activities of metal complexes particularly in oxidative processes by protecting 
the complex from oxidative degradation. 
The hypothesis is that surrounding the metal centre by a protein scaffold to provide control 
of the secondary coordination sphere could impact the selectivity of the reactions. The 
secondary coordination sphere provides additional possibilities to optimise the catalyst via 
protein engineering methods. An interesting example showed that hydrogen bonding 
provided by the protein scaffold in an ArM increased the stability of a key intermediate in 
biological and synthetic oxidations.38 
The aim of this work is to test a wide array of artificial metalloenzymes in the oxidation of 
lignin model compounds to determine if either selective oxidation or cleavage can be 
obtained.  Using both chemical methods and protein engineering methods, investigation to 
find the optimum conditions will be carried out to find the ideal catalyst.  
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4.2 Results 
Taking inspiration from the ligands used in homogenous oxidative catalysis, a library of 
maleimide modified nitrogen cofactors (Figure 4) was prepared as previously discussed in 
Chapter 2. This was used as a starting point because previous work by Stahl had shown that 
classic metal complexes such as Cu/bpy and Fe/phen are able to oxidise and in some cases 
break the β-O-4 linkage.39 However, in most cases both oxidation of the alcohols and cleavage 
of the lignin was observed with relatively low yields, and ArM’s provide an opportunity to 
improve upon this. 
 
Figure 4 - Library of maleimide modified nitrogen cofactors 
4.2.1 Lignin Model Compounds 
Lignin itself is very complex, therefore initial work on lignin oxidation and depolymerisation 
generally uses model compounds that simplify the main components. Several model 
compounds have been used in the literature from basic aryl ethers to synthetic polymers. 
Some models used for studying lignin, such as aryl ethers and guaiacol (Figure 5 Compound 
2 & 3 respectively) can be criticized as being too simple and not a reliable mimic of real 
lignin.  For this work compound 1 was chosen as the initial substrate, as it contains the main 
components of the β-O-4 linkage including the γ-hydroxyl moiety and is a better 
representative of how lignin would react. 
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Figure 5 – Range of Lignin Model Compounds studied varying in complexity. 
The lignin model compound was synthesised according to literature procedure40  shown in 
Scheme 2. While the synthesis of this model compound is well documented, several 
problems were encountered. The main issue occurred with the lithiation of 2-
methoy(phenoxy)acetate (4) and the trapping of the resulting enolate with veratraldehyde, 
to produce the β-hydroxy ester (5). Even with several attempts this reaction would not 
reach completion so required purification. Column chromatography to achieve good 
separation proved difficult. Good results were achieved using recrystallization conditions 
with 3:1 ethyl acetate and diethylether.  
 
 
 
 
 
 
  
 
Scheme 2 – Pathway to synthesise lignin model compound (1) 
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4.2.2 Oxidation catalysis of lignin model compounds 
Initially the first set of reactions with the lignin model substrate were to screen the 
cofactors without the protein to see if any benzylic oxidation occurs and also if any cleavage 
occurs. (Scheme 3) The initial screen predominately used iron triflate complexes of the ArM 
library in the oxidation of lignin model 1. 
 
Scheme 3 -  the observed products from either oxidation of the model compound or from 
cleavage of the β-O-4 linkage 
In acetonitrile, the TPA based cofactor (Cofactor D) + Fe(OTf)2 showed moderate conversion 
and a mixture of oxidation and cleavage products (Table 1, entry 2). However, repeating the 
reaction in buffer shut off all reactivity (Table 1, entry 1). The phenanthroline based cofactor 
(Cofactor Z) also showed conversion, however only a small percentage of benzylic oxidation 
was yielded. In buffer repeating this reaction it only managed to maintain a very small 
percentage of the activity seen in solvent.  The reactions with Cofactor Z showed an 
unknown product in small yield that could not be identified, so therefore its yield was 
calculated using the Rf of the substrate. 
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Entry Scaffold/Ligand Metal Oxidant 
Conversion 
(%) 
Yield (%)  
 5 mol% 5 mol% 1 equiv  A B C Unknown 
1 Cofactor D (in Buffer) Fe(OTf)2.2MeCN H2O2 0 - - -  
2 Cofactor D (in MeCN) Fe(OTf)2.2MeCN H2O2 45 8 20 10  
3 Cofactor E (in MeCN) Fe(OTf)2.2MeCN H2O2 - - - -  
4 Cofactor E (in Buffer) Fe(OTf)2.2MeCN H2O2 - - - -  
5 Cofactor Z (in MeCN) Fe(OTf)2.2MeCN H2O2 30 5 - - 8 
6 Cofactor Z (in Buffer) Fe(OTf)2.2MeCN H2O2 5 0.5 - - 3 
7 Cofactor Z (in MeCN) CuBr H2O2 8 2 - - 4 
8 Cofactor Z (in Buffer) CuBr H2O2 4 1 0.2 - 3 
Table 1 – Unmodified Transition Metal Catalysis of Lignin Model Compound Oxidation: 
Conditions: Catalyst formed in situ by addition of the metal precursor (5 mol%, in MeCN stock) Reactions 
carried out at 25 °C with 1 (1.23 µmol, added from a MeCN stock), H2O2 (1 eq.) in Mes buffer (50 mM, 20 mM 
NaCl, pH 6.5) or solvent where appropriate.  Conversions and yields were determined by HPLC with internal 
standard (Naphthalene), in triplicate. Unknown Product is a single peak yield calculated with RF for substrate 
 
4.3.3 Artificial metalloenzymes as oxidation catalysis of lignin model compounds 
The next step was to take the cofactors tested and utilise them within an ArM to see how 
the protein scaffold affected the reaction (Table 2). The pyridyl based Cofactors, D, E and X 
all showed oxidative activity to yield the benzylic oxidation product between 12 – 85%. The 
tris(2-pyridylmethyl)amine (TPA) based cofactor (Cofactor D) proved to be the most 
promising as it yielded the highest 85% of the benzylic oxidation product (Table 2, Entry 1). 
In the work using the cofactors by themselves, activity was predominately only seen in 
solvent, and buffer conditions stopped the activity. However, ArM activity is retained 
despite the aqueous environment and an increased selectivity was observed, with (6) being 
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the sole product observed. This is attributed to a discrete metal catalytic site being formed, 
as opposed to random iron coordination to the protein. To ensure this was the case and that 
the protein scaffold did not have any metal binding sites several controls were carried out 
(Table 3). No conversion was observed if Fe(OTf)2 is added directly to the WT SCP-2L protein 
(Table3, Entry 5). In order to ensure that oxidation was occurring from the ArM system and 
not any atmospheric oxygen, the reaction was carried out under an argon atmosphere both 
with and without the ArM (Table3, Entry 3 & 4).  
Additional evidence that a discrete metal catalytic site is formed is provided by the change 
in the extent of conversion when changing the site of modification within the protein 
scaffold. Both SCP-2L A100C and V83C are located at either end of the hydrophobic tunnel 
found in SCP-2L, but the surrounding protein environment for each clearly has an effect on 
the catalysts activity. SCP-2L V83C-D gave lower conversion and yield, suggesting the protein 
scaffold plays a role either in controlling substrate positioning/access or potentially though 
interactions that stabilise the catalytic metal centre. The electronic properties of the 
cofactors in the ArM’s also play a crucial role in the activity.  When the central nitrogen 
atom in E is varied by linking through an amide bond, cofactor Y, it proved to be detrimental 
to the catalytic activity as no reaction was observed. The cofactors based on the 
phenanthroline moiety (Cofactor Z) or the methyl TACN (Cofactor C) showed no oxidation 
activity at all. This is an interesting observation because in Chapter 2 the binding of metal to 
the modified protein was discussed and both Cofactor Z and C did not show the desired 1:1 
binding. 
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 Table 2 – ArM catalysed Lignin Model Compound Oxidation. Conditions : Reactions carried out at 
25 °C with 1 (1.23 µmol, added from a MeCN stock), H2O2 (1 eq.)  with rotation at 60 rpm, Buffer conditions 50 
mM MES buffer 20mM NaCl pH 6.0, Yields determined by HPLC with internal standard (napthalene) 
 
 
 
 
 
 
 
Table 3 –Controls for ArM catalysed Lignin Model Compound Oxidation: Conditions : Reactions 
carried out at 25 °C with 1 (1.23 µmol, added from a MeCN stock), H2O2 (1 eq.)  with rotation at 60 rpm, Buffer 
conditions 50 mM MES buffer 20mM NaCl pH 6.0, Yields determined by HPLC with internal standard 
(napthalene) *Reaction carried out under argon. 
Entry Scaffold/Ligand Metal Conversion (%) 
Yield (%) 
A B C 
1 SCP-2L A100C D Fe(OTf)2.2MeCN 100 85 - - 
2 SCP-2L A100C D FeCl3 0 - - - 
3 SCP-2L A100C D Mn(OAc)2 0 - - - 
4 SCP-2L V83C D Fe(OTf)2.2MeCN 85 70 - - 
5 SCP-2L A100C E Fe(OTf)2.2MeCN 35 28 - - 
6 SCP-2L V83C E Fe(OTf)2.2MeCN 0 - - - 
7 SCP-2L A100C Z Fe(OTf)2.2MeCN 0 - - - 
8 SCP-2L A100C X Fe(OTf)2.2MeCN 15 12 - - 
9 SCP-2L A100C Y Fe(OTf)2.2MeCN 0 - - - 
10 SCP-2L A100C C Fe(OTf)2.2MeCN 0 - - - 
Entry Scaffold/Ligand Metal Conversion (%) Yield (%) 
 5 mol% 5 mol% 
 
A B C 
1 -  Fe(OTf)2.2MeCN 0 -  - -  
2 -  - 0 -  - -  
3 - * - 0 -  - -  
4 SCP-2L A100C D* Fe(OTf)2.2MeCN 100 81 - - 
5 WT SCP-2L Fe(OTf)2.2MeCN 0 -  - -  
6 WT SCP-2L + Cofactor D Fe(OTf)2.2MeCN 0 -  - -  
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Looking at the current research of lignin oxidation, a wide array of metals have been used as 
previously discussed; therefore one interest was to explore if other metal precursors could 
be utilised in this ArM system. Mn-tpa complexes are also known oxidation catalysts,41 
however the addition of Mn(OAc)2 in situ to SCP-2L A100C-D did not result in an active 
catalyst. Fe(III) precursors were also inactive.  
4.2.4 Kinetic Study of Lignin Model Oxidation with ArM SCP-2L A100C-D-Fe2+ 
The next step was to try and gain a greater understanding of this reaction and obtain kinetic 
data. Initially attempts were made to see if it is possible to lower the catalyst loading. 
However, the results showed to be unsuccessful as the conversion was found to drop off 
sharply with decreased catalyst loading, particularly with SCP-2L V83C-D where a 7-fold 
decrease in activity is observed when halving the catalyst concentration from 5 mol% to 2.5 
mol% (Table 4). This was an indication that the reaction may follow non-first order kinetics, 
possibly the concentration is too close to the metal binding constant so the actual amount 
of catalyst present in the reaction may be lower than we are expecting. If any metal has 
dissociated from the ligand we would not expect this to cause any activity as we know that 
the free metal does not catalyse the reaction (Table 3, entry 1). 
 
Entry Scaffold/Ligand Metal loading (mol%) 
Conversion 
(%) Yield of A (%) 
1 
SCP-2L A100C-D 
5 100 85 
2 2.5 35 31 
3 1.25 0 0 
4 
SCP-2L V83C-D 
5 85 70 
5 2.5 12 7 
6 1.25 0 0 
 
Table 4: Metal loading optimisation Conditions: Reactions carried out at 25 °C with 1 (1.23 µmol, added 
from a MeCN stock), H2O2 (1 eq.)  with rotation at 60 rpm, Buffer conditions 50 mM MES buffer 20mM NaCl pH 
6.0, Yields determined by HPLC with internal standard (Naphthalene) *Reaction carried out under argon. 
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The formation of product 6 was then studied overtime as a function of the concentration of 
the substrate (0.6 – 2.8 mM). For each used substrate concentration, the concentration of 
the product was plotted against time and the initial rate of the reaction was determined 
from the linear part of the curve (Figure 6b). 
a) 
 
 
 
 
 
b) 
 
 
 
 
 
c) 
 
 
 
Figure 6 – a) Kinetic Study of the Formation of Product A with varying substrate 
concentration, b) Initial 5 mins used to calculate the velocity of the reaction. c) Calculated 
Initial Rate Error quoted for the 95% confidence level. 
Substrate conc. (mM) Initial rate,V0 (mM min-1) 
0.6 0.0247 ± 0.0002 
1.0 0.0407 ± 0.0001 
1.2 0.0491 ± 0.0038 
1.4 0.0572 ± 0.0002 
2.6 0.0964 ± 0.0064 
2.8 0.1067 ± 0.0067 
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The next step was to plot the initial velocity vs the varying substrate concentration in order 
to calculate the kinetic parameters. However, the results showed a linear trend and didn’t 
follow traditional Michaelis-Menten kinetics that you would expect from an enzyme, 
suggesting the ArM does not reach saturation kinetics. The assumption we can take from 
this is that the ArM acts more like a small molecular catalyst than an enzyme. By plotting a 
Lineweaver Burke plot the kinetic parameters can be calculated to give the kcat/KM =  (Figure 
7). Due to the fact that our ArM system does not reach saturation, the Vmax value is not 
reliable as the experimental is far away from that region. The calculated parameters 
obtained gives a value for kcat/KM = 0.697 min-1. The gradient = KM/Vmax = KM/kcat[E] = 23.65 
min. 
 
Figure 7 – Lineweaver Burke plot  
 
4.2.5 Varying the Substrate Scope of Lignin Model Compounds 
In order to explore how this reaction works, the substrate scope was expanded to look at a 
range of model compounds that mimic the β-O-4 linkage of lignin. As previously discussed a 
wide array of models has been studied in literature to mimic lignin (Figure 5). Therefore,  a 
selection of simple models were tested that could be used to explore how the different 
substituents in lignin may impact on the reactivity of the β-O-4 linkage. A variety of lignin 
model compounds were subjected to the optimum conditions (Scheme 4). Model 
compounds that did not contain the γ-hydroxyl showed much lower conversion than 
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previously studied substrate as they were not fully oxidised under the standard conditions. 
Introducing a phenol moiety increased conversion over the unsubstituted or methoxy 
substituted model compounds, albeit still with lower yields than observed with substrate 1.  
The initial results obtained with SCP-2L A100C-D-Fe2+suggested that it could be a good 
catalyst for simple benzylic oxidation. Therefore, SCP-2L A100C-D was tested in the 
oxidation of benzyl alcohol and 1-phenylethanol. Both primary and secondary benzylic 
alcohols are tolerated in the reaction giving moderate yields of the corresponding aldehyde 
or ketone.  Potentially the reduction in yield of the simple model compounds could be due 
to reduced water solubility of the lignin model.  It is also possible that the γ-hydroxyl is an 
important factor for selective conversion. 
 
Scheme 4 – Expanding the Substrate Scope for lignin model oxidation. Conditions: Reactions 
carried out at 25 °C with 1 (1.23 µmol, added from a MeCN stock), H2O2 (1 eq.)  with rotation at 60 rpm, Buffer 
conditions 50 mM MES buffer 20mM NaCl pH 6.0, Yields determined by HPLC with internal standard 
(Naphthalene) *Reaction carried out under argon. 
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4.2.6 Investigating ArM reactivity with Organic Solvent Tolerance 
A key drawback in most methodology developed on lignin model compounds is that they 
cannot be reproduced with real lignin. This is largely due to insolubility of real lignin in most 
solvents systems.  DMSO and dioxane are often solvents of choice for reactions with lignin. 
One limitation with ArM systems is that protein scaffolds tend to have very low tolerance to 
organic solvents, and denaturation is often seen. In order to test out this system the 
reactions were carried out in a buffer solvent mix to see how the activity is affected.  Both 
DMSO and dioxane were also shown to be tolerated as co-solvents under the standard 
reaction conditions, although substantial decreases in yields were observed (Table 5 Entry 1 
vs entries 4-7). The addition of MeCN as a co-solvent was tolerated up to 30% MeCN, albeit 
with reduced yields of 6 (Table 5). Increasing the co-solvent ratio to 50% led to very low 
levels of activity. In order to improve upon this protein engineering methods could be used 
to increase the proteins stability with respect to organic solvents.42  
 
 
 
Table 5: Co-solvent tolerance Conditions : Reactions carried out at 25 °C with 1 (1.23 µmol, added from a 
MeCN stock), H2O2 (1 eq.)  with rotation at 60 rpm, Buffer conditions 50 mM MES buffer 20mM NaCl pH 6.0, 
Yields determined by HPLC with internal standard (Napthalene) *Reaction carried out under argon. 
 
O
O
OH
OH
O
O
1
Ligand (5 mol%)
Metal precursor (5 mol%)
H2O2 (1 equiv), MES Buffer
pH 6.5, 25 °C , 1h
O
O
O
OH
O
O
6
Entry Solvent (Ratio) Conversion (%) Yield of A (%) 
1 MES 100 85 
2 MES : MeCN (7:3) 54 41 
3 MES : MeCN (1:1) 12 5 
4 MES : Dioxane (7:3) 38 35 
5 MES : Dioxane (1:1) 0 0 
6 MES : DMSO (7:3) 57 53 
7 MES : DMSO (1:1) 9 8 
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4.2.7 Mutants to increase cofactor stability 
In order to learn more about the ArM activity further characterisation was required, 
because we had no evidence where the metal ion sits within the protein and which 
surrounding amino acids it can interact with.  Attempts to characterise the obtained ArM 
with MS were unsuccessful and we were unable to obtain crystal structures of any of the 
modified proteins SCP-2L A100C/V83C-X, or their metal complexes. Therefore, in parallel to 
this work, MD simulations were carried out to attempt to probe the position of the 
cofactors in the protein and any interactions that could be observed.  
4.2.7.1 Design of mutants in which protein secondary coordination sphere would stabilize 
cofactor 
MD simulations were carried out by Michael Buehl, Jan Goetze and Jonathan Colburn. The 
system used to model was SCP-2L A100C modified with Cofactor C.  
One complication with the MD simulation is that modifying the unique cysteine residue has 
the ability to produce two diastereoisomers and it is not possible to determine which is 
seen. MD simulations were therefore carried out with each diastereoisomer, and as 
expected slightly different distances and interactions were observed for each 
diastereoisomer. The MD simulations showed close interactions of the target construct 
mainly with the Phe93/Phe94 cluster of a nearby alpha helix. Phe94 was identified as a 
potential mutation target to introduce coordinating amino acids. (Figure 8) Phe94 was 
chosen as a preference over Phe93 because it is believed Phe93 is involved in maintaining 
the structure of the hydrophobic tunnel.  
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Figure 8 – Closing arrangement of the “head” of the hydrophobic channel in the two 
diastereoisomeric arrangements of the bound ligand. Left: S-stereoisomer with open 
channel. Right: R-stereoisomer with closed channel due to stacked Phe93/ligand rings and 
Phe93/Ile interactions. MD simulations were carried out by Michael Buehl, Jan Goetze and 
Jonathan Colburn.1 
Amino acids that can coordinate to metals such as His or Glu are known to stabilise Fe-O2 
and Fe-OOH intermediates either directly or through hydrogen bonding in a number of 
enzymes.43, 44 A similar concept is shown by adding acetic acid to oxidation reactions 
catalysed by iron complexes, and this was shown to improve yields, possibly by stabilisation 
of iron intermediates. The mutants SCP-2L A100C F94E and F94H were designed, expressed 
and purified. 
4.2.7.2 Lignin model oxidation with mutant in optimum conditions 
The same optimum conditions were used to test the new mutants to see how what affect 
they would have on the reactivity. As the Cofactor D showed full conversion of the substrate 
at a catalytic loading of 5 mol%, the loading was reduced to 2.5 mol% in order to see if any 
changes occur by introduction of a His or Glu amino acid in the protein scaffold. 
The introduction of His at position 94 had no influence on the reaction; however, the 
introduction of Glu had a positive influence on the reactivity increasing the observed yield. 
The increase was most remarkable with cofactor SCP-2L A100C-E, where the yield doubled on 
the introduction of Glu. Acetic Acid was added to the reaction in order to see if it would mimic 
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the same changes as introducing Glu to the protein scaffold. Smaller increases were observed 
when acetic acid was added as an additive (Table 6). 
 
Scaffold/Ligand Metal 
Acetic Acid Conversion 
(%) 
Yield (%) 
2.5 mol% 2.5 mol%   A B C 
SCP-2L A100C D Fe(OTf)2.2MeCN - 35 31 - - 
SCP-2L A100C F94E D Fe(OTf)2.2MeCN - 47 43 - - 
SCP-2L A100C F94H D Fe(OTf)2.2MeCN - 35 29 - - 
SCP-2L A100C  D Fe(OTf)2.2MeCN 1 equiv 40 36 - - 
SCP-2L A100C  D Fe(OTf)2.2MeCN 5 equiv 53 48 - - 
5 mol% 5 mol%   A B C 
SCP-2L A100C E Fe(OTf)2.2MeCN - 35 28 - - 
SCP-2L A100C F94E E Fe(OTf)2.2MeCN - 59 54 - - 
SCP-2L A100C F94H E Fe(OTf)2.2MeCN - 35 30 - - 
SCP-2L A100C  E Fe(OTf)2.2MeCN 1 equiv 45 41 - - 
Table 6 – Lignin Model Compound Oxidation with SCP-2L A100C F94E/H Conditions : Reactions 
carried out at 25 °C with 1 (1.23 µmol, added from a MeCN stock), H2O2 (1 eq.)  with rotation at 60 
rpm, Buffer conditions 50 mM MES buffer 20mM NaCl pH 6.0, Yields determined by HPLC with internal 
standard (Napthalene) 
O
O
OH
OH
O
O
1
Ligand (5 mol%)
Metal precursor (5 mol%)
H2O2 (1 equiv), MES Buffer
pH 6.5, 25 °C , 1h
O
O
O
OH
O
O
6
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Further MD similations were carried out looking at the Glu mutant to see if closer contact 
between the carboxylate side chain and the metal is seen. Within the simulations an Asp 
was used in the place of Glu because of the shorter side chain there are less conformational 
degrees of freedom to explore. The initial MD simulations were carried out with TACN based 
cofactor, so the same was utilised in these studies. The simulations showed that on average 
the carboxylate side chain was closer to the metal the original protein. For a short period 
the carboxylate side chain came withing hydrogen bonded distance to a water ligand 
coordinated to the metal ( between 1.7 – 2ns in Figure 9, see Figure 10 for a snapshot from 
this region). 
 
Figure 9: Fluctuations of the distances between the metal and selected points of the side 
chain of residue 94 during 2 ns of MD of the protein-ligand complex (results shown for the S-
isomer); in black: WT (distance to C  of Phe94), in red: F94D mutant (distance to the centre 
of mass of the two carboxylate O atoms, which, when Phe and Asp residues are overlaid, is 
very close to the position of C ). MD simulations were carried out by Michael Buehl, Jan 
Goetze and Jonathan Colburn.1 
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Figure 10: Snapshot from the simulation of the F94D mutant showing a close contact 
between the carboxylate side chain and the metal fragment (distance in Å). MD simulations 
were carried out by Michael Buehl, Jan Goetze and Jonathan Colburn.1 
Overall, it has been demonstrated that ArMs can be used to change the selectivity of 
chemical reactions compared to the parent small molecule catalysts, producing selective 
catalysts. Complete selective conversion to the ketone product from the lignin model 
compound was seen using SCP-2L A100C modified with a tris(2-pyridylmethyl) amine based 
cofactor, complexed with Fe(OTf)2.2MeCN. Engineering the protein scaffold to incorporate 
glutamic acid was found to improve the ArM activity.  This demonstrated that rational 
design of the surrounding protein environment using metal binding amino acids can be used 
to improve the overall activity of an artificial metalloenzyme. 
Previous use of protein engineering in increasing the activity of a hydroformylase, shown in 
chapter 3, suggests that further engineering of the ArMs could produce a more stable 
protein that could potentially be tolerable to organic solvents. Further optimisation of the 
ArM system could provide a pathway to the ideal catalyst for selective lignin oxidation and 
also degradation. 
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4.3 Experimental  
4.3.1 General Remarks 
All reagents and solvents were obtained commercially and used without further purification. 
The nBuLi was titrated against 2-3 dimethoxybenzyl alcohol prior to use to determine the 
correct concentration. Thin layer chromatography was performed on silica plates (TLC silica 
gel 60 F254 Merck) and visualised with UV light (254nm). Column chromatography was 
performed using silica gel 60 particle size 40-63μm from Merck. NMR spectra were taken at 
room temperature with Bruker Avance 300, 400 or 500 NMR spectrometers. Chemical shifts 
(δ) are given (in ppm) and processed using MestReNova software. The residual 
undeuterated solvent of the deuterated solved used (CHCl3 δ = 7.26 and 77.16, 1H and 13C 
respectively) was used to reference the chemical shifts. The abbreviations for the 
multiplicity of the proton, carbon and fluorine signals are as follows: s singlet, d doublet, dd 
doublet of doublets, ddd doublet of doublet of doublets, t triplet, dt double triplets, q 
quartet, m multiplet, br s broad singlet.  
UV-visible measurements were recorded on a Molecular Devices M2 Spectra Max 
spectrophotometer. 
4.3.2 Protein Expression and purification: 
SCP-2L A100C and V83C were expressed and purified as described before.45 The same 
method was used for SCP-2L A100C F94H and F94E giving yields of 20 mgL-1 and 25 mgL-1 
respectively. Mutations were introduced using the Quick-Change Site-Directed Mutagenesis 
Kit (Stratagene) with pEHISTEV::dΔhΔSCP-2L as the template. The primers used for the 
mutagenesis are shown below. The constructs were verified by sequencing by GATC. 
SCP2L A100C F94E 
5’ CCT CAG AAG GCA TTC GAA AGT GGC AGG CTG AAG 3’ 
5’ CTT CAG CCT GCC ACT TTC GAA TGC CTT CTG AGG 3’ 
SCP2L A100C F94H 
5’ CCT CAG AAG GCA TTC CAT AGT GGC AGG CTG AAG 3’ 
 104 
5’ CTT CAG CCT GCC ACT ATG GAA TGC CTT CTG AGG 3’ 
The constructs were prepared as follows: SCP-2L A100C was used as the template DNA. Site 
directed mutagenesis was carried out. The reaction was set up as follows: Primer fw: 0.01 
μM (0.25 μM, 0.5 μL), primer rv: 0.01 μM (0.25 μM, 0.5 μL), SCP-2L template DNA (0.5 μL), 
PfuUltra Master Mix (10 μL), Sterile MilliQ Water. 
After mixing, the PCR tubes are shortly spun (4 sec, table top centrifuge, RT). The tubes are 
transferred to a PCR machine and the following PCR cycle is run. 
1.  Initial Denaturation 95 °C, 5 min 
2. Denaturation 30 sec 95 °C 
3. Annealing 1min 55 °C 
4. Extension 1min/1kp 72 °C 
5. Repeat Steps 2-4 for 16 cycles 
6. Final extension 20 min 72 °C 
Digestion of the wild type template strand was then performed as follows: PCR product (8.5 
μL), 10x Fast digest buffer (1 μL) and Dpn1 (0.5 μL) were incubated at 37 °C for 10 min, 
followed by inactivation at 72 °C for 5 min. The digested products were transformed into 
commercial DH5α cells and grown on kanamycin (50 μg/mL) agar plates at 37 °C overnight. 
One to two colonies were observed for each mutant. The DNA was obtained via a miniprep 
kit and sent for sequencing at GATC Biotech Co., UK. 
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SDS Gel to show purification of SCP-2L A100C F94H (left) and SCP-2L A100C F94E (right) 
 
 
 
 
 
 
 
 
 
 
L. SeeBlue Plus 2 Prestained Protein Standard 
1. SCP-2L A100C F94H Supernatant 
2. SCP-2L A100C F94H Supernatant 
3. Wash through from Nickel Column 
4. High Salt Wash from Nickel column 
5. Elution His - Tagged Protein  
6. Pure SCP-2L A100C F94H 
7. SCP-2L A100C F94E Supernatant 
8. SCP-2L A100C F94E Supernatant 
9. Wash through from Nickel Column 
10. High Salt Wash from Nickel column 
11. Elution His - Tagged Protein  
12. His Tagged Cleaved Protein 
13. Pure SCP-2L A100C F94E 
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4.3.3 LCMS analysis of new SCP-2L A100C mutants F94E/H and the relative modified ArM’s 
LC-MS(ES+) used for analysis of protein and conjugation-reactions was performed on a 
Waters Alliance HT 2795 equipped with a Micromass LCT-TOF mass spectrometer, using 
positive electrospray ionisation and applying a Waters MASSPREP® On-line Desalting 2.1x10 
mm cartridge using a gradient of 1% formic acid in H2O to 1% formic acid in acetonitrile. ESI-
MS results were analysed by MassLynx V. 4.0 and its MaxEnt algorithm. 
 
SCP 2L A100C F94H: Calculated mass: 13522.8 Da Observed: 13522.5Da.  
 
SCP 2L A100C F93E: Calculated mass: 13514.8 Da Observed: 13514.1 Da.  
 
 
 
 
 
SCP 2L A100C F94H-TPA: Calculated mass: 13922.8 Da Observed: 13922.9Da.  
 
SCP 2L A100C F93E-TPA: Calculated mass: 13914.8 Da Observed: 13914.1 Da. 
  
 
 
 
 
 
SCP 2L A100C F94H-TPA: Calculated mass: 13846.8 Da Observed: 13846.5 Da.  
 
SCP 2L A100C F93E-TPA: Calculated mass: 13814.8 Da Observed: 13838.0 Da.  
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4.3.4 Lignin Model Compound Synthesis- Carried out according to published literature38 
Step 1: Synthesis of Ethyl(2-methoxyphenoxy)acetate (4) 
 
 
A solution containing guaiacol (80 g, 1 equiv., 644 mmol) in acetonitrile (600 mL) and K2CO3 
(115.6 g, 1.3 equiv., 838 mmol) was stirred for one hour at room temperature. The reaction 
mixture was then cooled to 0 °C and ethyl bromoacetate (120 g, 1.12 equiv., 718 mmol) was 
added dropwise over a period of 30 mins and then stirred for an hour at 0 °C. The reaction 
mixture was filtered, and the light blue filtrate was collected. The reaction mixture was 
dissolved in water (200 mL) and the product was extracted using ethyl acetate (400 mL). The 
organic layer was dried over MgSO4, filtered and concentrated. The product was washed 
with 1M NaOH (300 mL) and then dried under vacuum to give the product as dark yellow oil. 
(41.2 g, 33% yield). 
1H NMR (500MHz, CDCl3, TMS): δ 6.88–6.70 (m, 4H, Hd-g), 4.57 (s, 2H, Hc), 4.24 (q, J = 7.1Hz, 
2H, Hb), 3.73 (s, 3H, Hh), 1.27 (t, J = 7.2Hz, 3H, Ha) 
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Step 2: erythro-ethyl 3-(3,4-dimethoxyphenyl)-3-hydroxy-2-(2-
methoxyphenoxy)propanoate (5) 
 
 
 
 
Diisopropylamine (5.1 mL, 36.1 mmol, 1.2 equiv.) in dry THF (40 mL) is stirred under argon at 
-78°C. 2.3M nBuLi (14.4ml, 36.1mmol, 1.2 equiv) was added dropwise to the reaction over a 
period of 30mins and then stirred for a further 30 mins at -78°C. Ethyl(2-
methoxyphenoxy)acetate (7.6g, 36.1mmol, 1.2 equiv) is added dropwise over a period of 30 
mins and then stirred for a further 60 mins at -78°C and the reaction turned from colourless 
to yellow. Veratrylaldehyde (5g, 30.1mmol, 1 equiv) was added to the reaction mixture and 
then was stirred for a further 3 hours at 78°C during which time the reaction mixture turned 
cloudy. The reaction mixture was raised from the ice bath and allowed to warm up to room 
temperature, then the reaction mixture was diluted with water. The product was then 
extracted with ethyl acetate (4 x 50 ml) and the organic fraction was dried over MgSO4, 
filtered and concentrated. The solid product was recrystallized from ethanol/ hexane (3:1) 
and the product washed with diethyl ether to give a white solid. (2.4g, 21% yield).  
M.p. 104-105 °C 
1H NMR (500MHz, CDCl3): δ 7.07 (d, J = 2.0 Hz, 1H, Ar-H), 7.05-6.99 (ddd, J = 8.2, 5.2, 1.6 Hz, 
2H, Ar-H), 6.88-6.84(m, 2H, Ar-H), 6.84-6.82 (m, 2H, Ar-H), 5.14 (br t, J = 3.8 Hz, 1H, OH), 
4.74 (d, J = 5.0 Hz, 1H, Hi), 4.16 (q, J = 5.0 Hz, 2H, Hg), 3.90 (s, 3H, Ha), 3.89 (s, 3H, Hl), 3.87 (s, 
3H, Hm), 3.66 (d, J = 5.8 Hz, 1H), 1.15 (t, J = 7.1 Hz, 3H, Hh) 
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Step 3: Synthesis of 1-(3,4-dimethoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol – 
Model Compound (1) 
 
 
 
 
β-Hydroxy ester (5) (0.88 g, 1 equiv., 2.34 mmol) in 3:1 THF/H2O (13 mL) was stirred at room 
temperature and NaBH4 (0.44g, 5 equiv, 11.7mmol) was added to the reaction mixture, 
which was stirred overnight. Water was added to the quench the reaction mixture, and then 
the product was extracted using ethyl acetate. The organic fraction was dried over MgSO4, 
filtered and concentrated to produce a viscous yellow oily solid. (0.67g, 85% yield). 
Mp 104-105 °C 
1H NMR (500 MHz, CDCl3) δ 7.10 (ddd, J = 8.1, 7.3, 1.8 Hz, 1H, Ar-H), 7.02-6.90 (m, 5H, Ar-H), 
6.86 (d, J = 8.2 Hz, 1H, Ar-H), 5.01 (dt, J = 4.6, 1.8 Hz, 1H, Hj), 4.19 (ddd, J = 6.1, 4.7, 3.4 Hz, 
1H, Hh), 3.95 (m, 1H, Hi), 3.92 (s, 3H, Ha), 3.91 (s, 3H, Ho), 3.90 (s, 3H, Hp), 3.68 (ddd, J = 12.4, 
7.3, 3.4 Hz, 1H, Hi), 3.49 (br s, 1H, OH), 2.73 (br s 1H OH) 
13C NMR (126 MHz, CDCl3) δ 151.7 (Ar-C), 149.0 (Ar-C), 148.5 (Ar-C), 146.8 (Ar-C), 132.3 (Ar-
C), 124.4 (Ar-C), 121.7 (Ar-C), 121.2 (Ar-C), 118.4 (Ar-C), 112.2 (Ar-C), 111.0 (Ar-C), 109.1 (Ar-
C), 87.6 (Ch), 72.7 (Cj), 60.7 (Ci), 55.9 (Ca,o,p) 
Spectral data corresponds to those given in literature38 
HRMS (ESI) m/z [MNH4]+ 352.1756 (calculated C18H22O6NH4 352.1755) 
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4.3.5 Lignin Model Compound Oxidation  
General procedure: The modified protein (MES Buffer 50 mM MES, 20 mM NaCl, pH 6.5) is 
incubated while shaking (60 rpm) with the metal salt to pre-form the complex for 20 mins. 
The substrate (1.23 µmol) is added to the complex (5 mol%) in 50µl MeCN. H2O2 (1 equiv.) is 
then added to the reaction mixture in one addition and the reaction mixture is shaken for 60 
minutes. To stop the reaction 500 µl DCM is added, the reaction mixture is then centrifuged 
for 2 mins 13000 rpm to remove the catalyst and the product and any remaining starting 
material are extracted as the organic layer. Analysis is then carried out using HPLC. 
HPLC Conditions: HPLC analysis was performed using an Agilent Eclipse XDB-C18 5 Column 
(5 μm 4.6 x 150 mm). Naphthalene was used as internal standard. All samples were analyzed 
using a MeCN (0.1% formic acid) (A)/H2O(0.1% formic acid) (B) gradient with a flow rate of 
1.0 ml/min. HPLC Method: 5% A/95% B for 10 minutes followed by gradient to 95% A/5% B 
over 30 minutes followed by 10 minutes at 95% A/5% B followed by a gradient to 5% A/95% 
B over 5 minutes followed by 5 minutes at 5% A/95% B a flow rate of 1.0 mL/min. Results 
were analysed at 270nm. 
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 Retention 
Time 
Dilignol Model Substrate (1) 22.08 
Secondary Ketone Dilignol Model (6) 24.52 
Veratraldehyde  20.96 
Guiacol 18.94 
Napthalene 32.44 
 
Example HPLC trace of SCP-2L A100C -D-Fe(Otf)2.2MeCN oxidation with Lignin Model Compound 1 
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Benzylic Oxidation β-O-4  cleavage
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Kinetics: The kinetics for the oxidation of 1 catalysed by ArM SCP-2L A100C-TPA-Fe2+ was 
determined. All measurements were performed at 25 °C in MES Buffer 50 mM MES, 20 mM 
NaCl, pH 6.0. Analysis was performed by HPLC (conditions given previously) monitoring the 
formation of product 6 overtime as a function of the concentration of the substrate. (0.6 – 
2.8 mM). 
The catalytic solution was prepared in the same manner as the standard reactions, by 
combining the modified ArM (61.5 µM, 5 mol%) with Fe(OTf)2.2MeCN (61.5 µM 5 mol%) 
allowing the complex to form for 20 mins by shaking at 60 rpm. Substrate 5 (0.6 – 2.8 mM) 
and 1 equivalent of H2O2 (1.23 mM) is added to begin the reaction in a final volume of 1000 
µl. To stop the reaction 500 µl DCM was added at the appropriate time point, the reaction 
mixture was then centrifuged for 2 mins 13000 rpm to remove the catalyst and the product 
and any remaining starting material were extracted as the organic layer. Analysis was then 
carried out using HPLC. 
For each used substrate concentration, the concentration of the product was plotted 
against time and the initial rate of the reaction was determined from the linear part of the 
curve, using linear regression in Prism Graphpad 7.0 software.   
1 M. V. Doble; A. G. Jarvis; A. C. C. Ward; J. D. Colburn; J. P. Gotze; M. Buhl; P. C. J. Kamer. 
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Chapter 5 - Summary and Conclusion 
 
This thesis has studied the design, synthesis, application and optimisation of ArM systems. 
The artificial metalloenzyme is based on a concept which is depicted in figure 1. The 
catalytic performance of these hybrid catalysts has been optimized by using orthogonal 
structural-diversity generating procedures: molecular biology for the optimization of the 
protein structure and synthetic chemistry to tune the structure of the ligand.  
 
 
 
 
 
 
 
 
 
 
Figure 1- Schematic representation of artificial metalloenzymes obtained by covalent 
modification 
 
In Chapter 2 a library of ArMs was successfully made using a designed cofactor library and 
two variants of SCP-2L as the protein scaffold. When using ArM systems in catalysis, it is 
important to have an accurate method for characterising the catalyst as the synthetic 
cofactor can cause typical protein protocols to become unreliable. When studying modified 
SCP-2L A100C in chapter 2, it was shown that normal methods for determining protein 
concentration such as a Bradford assay could not be relied upon. Instead an accurate 
extinction coefficient was determined experimentally and varied greatly depending on 
which cofactor was present.  
 
In chapter 3, the synthesis and application of an ArM for transition metal catalysed 
reactions not performed by natural enzymes was described. In hydroformylation reactions, 
an engineered thermostable ArM improved the TON over 5-fold.  By improving the stability 
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of the protein scaffold in the ArM, it provides a much wider selection of reaction conditions 
that can be used and therefore increases the chances of finding a more active catalyst. 
 
ArM systems were utilised in looking at lignin model compound oxidation in chapter 4. In 
this scenario the incorporation of the TPA ligand within a protein scaffold gave rise to 
selective benzylic alcohol oxidation (Figure 2) The observation that the conversion can be 
increased by mutations in the surrounding protein environment, suggests that future 
genetic optimisation of the protein will lead to more active enzymes that can be used for 
larger scale processes and ultimately within the biorefinery.   
 
 
 
 
 
 
 
 
 
Figure 2- selective benzylic alcohol oxidation of lignin model compound 
 
 
Overall, this study demonstrates that judiciously chosen protein binding scaffolds can be 
adapted to obtain enzymes that provide the reactivity of the introduced metal centre 
combined with specifically intended product selectivity. Such approaches should inspire the 
development of new catalytic systems that utilize the powerful substrate binding 
capabilities of proteins. In the long term, as chemogenetic optimisation is used to improve 
activity, this could open the door to a new era of biocatalytic chemical production.  
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